Method and system for classifying analyte data into cluster

An automated classification process using regression models and clustering algorithms addresses the issues of manual gating variability in flow cytometry, improving singlet identification and removing debris/multiplets, enhancing data purity and analysis reliability.

JP2024163984APending Publication Date: 2024-11-26BECTON DICKINSON & CO
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
JP2024076706
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-05-09
Filing Date
2024-05-09
Publication Date
2024-11-26

AI Technical Summary

Technical Problem

Current flow cytometry data analysis methods rely heavily on manual gating, which can lead to incorrect classification of analytes, particularly singlets, and vary widely between users, affecting reproducibility and generalizability, and often fail to efficiently remove debris and multiplets.

Method used

An automated process using regression models and classification algorithms, such as Gaussian mixture models, DBSCAN, BIRCH, and K-means clustering, to classify analyte data into clusters, improving the accuracy and efficiency of singlet identification and removing debris and multiplets.

Benefits of technology

The method significantly reduces the manual effort and variability in data classification, achieving up to 97% accuracy in singlet classification and effectively excluding non-singlets, thereby enhancing the purity and reliability of downstream analyses.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2024163984000001_ABST
    Figure 2024163984000001_ABST
Patent Text Reader

Abstract

To remove data associated with undesirable analyte (for example, debris, multiplet and the like)SOLUTION: A computer-implemented method is provided that classifies analyte data. A method of interest includes: applying a regression model to determine a relationship between an initial set of analyte features and a cluster criterion; generating a sparse set from at most a portion of the initial set of the analyte features based on the relationship; generating a classification model based on the sparse set; and applying the classification model to classify the analyte data into a cluster. A system and non-transitory computer-readable storage medium are provided that are configured to carry out the subject method.SELECTED DRAWING: Figure 1
Need to check novelty before this filing date? Find Prior Art

Description

[Background technology]

[0001] Characterization of analytes in biological fluids has become an important part of bioresearch, medical diagnosis, and evaluation of a patient's overall health and wellness. Detecting analytes in biological fluids, such as human blood or blood-derived products, can provide results that can play a role in determining treatment protocols for patients with various disease states.

[0002] Flow cytometry is a technique used to characterize and often sort biological materials, such as cells in a blood sample, or particles of interest in another type of biological or chemical sample. A flow cytometer typically includes a sample reservoir for receiving a fluid sample, such as a blood sample, and a sheath reservoir that contains a sheath fluid. The flow cytometer directs the sheath fluid to the flow cell while transporting particles (including cells) in the fluid sample as a cell stream to the flow cell. To characterize the components of the flow stream, light is illuminated onto the flow stream. Variations in the material in the flow stream, such as morphology or the presence of fluorescent labels, can cause variations in the observed light, and these variations allow for characterization and separation. To characterize the components in the flow stream, light must impinge on the flow stream and be collected. Light sources in flow cytometers can vary and can include one or more broad spectrum lamps, light emitting diodes, and single wavelength lasers. The light source is aligned with the flow stream, and optical responses from the illuminated particles are collected and quantified.

[0003] Isolation of biological particles has been achieved by adding sorting or collection capabilities to flow cytometers. Particles in the separation stream that are detected as having one or more desired properties are individually isolated from the sample stream by mechanical or electrical removal. A common flow sorting technique utilizes droplet sorting, where a fluid stream containing linearly separated particles breaks into droplets. Droplets containing particles of interest are electrically charged and deflected into a collection tube by passing through an electric field. Typically, linearly separated particles in the stream are characterized as they pass an observation point located just below the nozzle tip. Once a particle is identified as meeting one or more desired criteria, it is possible to predict the time at which the particle will reach a break-off point and break off into a droplet from the stream. Ideally, a small charge is applied to the fluid stream just before the droplet containing the selected particle breaks off from the stream and is grounded just after the droplet breaks off. The droplet to be sorted maintains its charge as it breaks off from the fluid stream, while all other droplets remain uncharged.

[0004] Parameters measured using a flow cytometer typically include light at the excitation wavelength scattered by the particles at a narrow angle along the approximately forward direction, referred to as forward scatter (FSC), excitation light scattered by the particles in a direction orthogonal to the excitation laser, referred to as side scatter (SSC), and light emitted by fluorescent molecules at one or more detectors that measure signals over a range of spectral wavelengths, or by fluorescent dyes that are detected primarily at that particular detector or detector array. Different cell types can be distinguished by their light scattering properties and fluorescent emissions resulting from labeling various cellular proteins or other components with fluorochrome-labeled antibodies or other fluorescent probes.

[0005] The flow cytometer may further include means for recording the measured data and analyzing the data. For example, data storage and analysis may be performed using a computer connected to the detection electronics. For example, the data may be stored in a table format, with each row corresponding to data for one particle and columns corresponding to each of the measured characteristics. The use of a standard file format, such as the "FCS" file format, for storing data from a particle analyzer makes it easy to analyze the data using a separate program and / or machine. Using current analysis methods, the data is typically displayed in a one-dimensional histogram or two-dimensional (2D) plot for ease of visualization, although other methods may be used to visualize multi-dimensional data.

[0006] Flow cytometer data generally contain many data points (i.e., events), but often only certain portions of the flow cytometer data are of interest to the user. For example, it may be desirable to identify the best parameters to distinguish debris / small particles from single cells and multiplets. Debris is essentially cellular pieces that have been broken during processing. Multiplets are two or more cells that are joined together. Cellular debris can be considered as "junk" or data that the user does not want to collect or process in further analysis. Multiplets are also events that are desirable to remove from the analysis because the fluorescent signal obtained from them is double that which would be observed from a single cell, i.e., they are anomalous events. Removal of such debris and multiplets is often the first step performed in the analysis of flow data. In other words, exclusion of doublets and clumps is an important preliminary step to establishing a pure sort. Doublets can confound purity and result in undesired results or unnecessary costs when performing downstream functional and / or genomic analysis. Summary of the Invention

[0007] The present disclosure provides for improving the process in which analyte data (e.g., flow cytometer data) is classified, for example, in the process of removing data associated with undesired analytes (e.g., debris, multiplets, etc.). It has been found that manual gating of singlets (SSC-A vs. FSC-A) can result in 40% of true non-singlets being misclassified as singlets. Furthermore, analyte classification often varies widely between different users, thereby hindering generalizability and reproducibility of results. Thus, a simplified process for data cleanup is desirable. In particular, there is a need for an automated process for cleaning data that minimizes removal of events of interest that can result from drawing manual gates. Embodiments of the present disclosure meet these and other needs.

[0008] Aspects of the present disclosure include computer-implemented methods of classifying analyte data. The subject methods include, via a processor, applying a regression model to determine a relationship between an initial set of analyte features and a cluster criterion, generating a sparse set from at most a portion of the initial set of analyte features based on the relationship, generating a classification model based on the sparse set, and applying the classification model to classify the analyte data into clusters. In some embodiments, the analyte data is flow cytometer data. In some such embodiments, the cluster criterion is an association of the analyte data with singlets. In certain cases, the clusters include singlet clusters and non-singlet clusters. In some versions, the analyte features include size features, imaging features, scattering features, or any combination thereof. In some cases, the classification model includes a mixture model, such as a Gaussian mixture model. In other cases, the classification model includes a density-based spatial clustering for applications with noise (DBSCAN) algorithm. In still other cases, the classification model includes a balanced iterative reducing and clustering using hierarchies (BIRCH) algorithm. In yet other cases, the classification model includes a K-means clustering algorithm. In further cases, the classification model includes a spectral clustering algorithm. In some cases, the initial set of analyte features includes between 5 and 20 analyte features (e.g., between 9 and 11 analyte features). In one particular version, the sparse set of analyte features includes between 2 and 10 analyte features (e.g., between 2 and 4 analyte features). In one particular version, classifying the analyte data includes including 90% or more (e.g., 97% or more) of the analyte data associated with the cluster criteria in a cluster associated with the cluster criteria. In some cases, classifying the analyte data includes excluding 85% or more (e.g., 92% or more) of the analyte data not associated with the cluster criteria from a cluster associated with the cluster criteria.

[0009] Aspects of the present disclosure additionally include systems. The subject systems include a memory operably coupled to a processor, the memory including instructions stored in the memory, which when executed by the processor, cause the processor to perform the methods of the present disclosure (e.g., as described above and herein). In other words, the processor is configured to apply a regression model to determine a relationship between an initial set of analyte features and cluster criteria, generate a sparse set from at most a portion of the initial set of analyte features based on the relationship, generate a classification model based on the sparse set, and apply the classification model to classify the analyte data into clusters. In some cases, the system is or includes (e.g., is operatively connected to) a flow cytometer. In some versions, the flow cytometer is an imaging-enabled flow cytometer. The methods of the present disclosure may, in some cases, involve providing analyte data to the system of the present disclosure and receiving classified analyte data from the system.

[0010] Aspects of the present disclosure also include a non-transitory computer-readable storage medium having stored thereon instructions for classifying analyte data according to the methods of the present disclosure, in other words, applying the classification model to classify the analyte data by applying a regression model to determine a relationship between an initial set of analyte features and a cluster criterion, generating a sparse set from at most a portion of the initial set of analyte features based on the relationship, generating a classification model based on the sparse set, and classifying the analyte data into clusters.

[0011] The present disclosure can be best understood from the following detailed description when read in conjunction with the accompanying drawing figures, which include the following figures: [Brief description of the drawings]

[0012] [Figure 1]1 presents a flowchart for implementing a method for classifying analyte data in accordance with certain embodiments. [Diagram 2] A flow cytometry system according to certain embodiments is presented. [Figure 3-1] 1 depicts an imaging-enabled particle sorter in accordance with certain embodiments. [Figure 3-2] 1 depicts an imaging-enabled particle sorter in accordance with certain embodiments. [Figure 4] 1 depicts a functional block diagram of a particle analysis system in accordance with certain embodiments; [Diagram 5] 1 depicts a functional block diagram for one example of a control system in accordance with certain embodiments. [Figure 6A] 1 depicts a schematic diagram of a particle sorter system in accordance with certain embodiments; [Figure 6B] 1 depicts a schematic diagram of a particle sorter system in accordance with certain embodiments; [Figure 7] 1 depicts aspects of a computer control system according to certain embodiments. [Figure 8A] 1 illustrates a flowchart for performing feature selection. [Figure 8B] Illustrates a flowchart for implementing Gaussian Mixture Modeling. [Figure 9] The imaging features used in the manual gating method and the distribution of lymphocytes, monocytes and high scatter events are plotted. [Figure 10A] Results from non-singlet exclusion of imaging alone are plotted. [Figure 10B] Results from non-singlet exclusion of imaging alone are plotted. [Figure 11A] Plot the results using height vs. width + imaging non-singlet exclusion method. [Figure 11B] Plot the results using height vs. width + imaging non-singlet exclusion method. [Figure 12A] Results are plotted using height vs. area + imaging non-singlet exclusion method. [Figure 12B]Results are plotted using height vs. area + imaging non-singlet exclusion method. [Figure 13A] Compare non-singlet exclusion and singlet preservation between the different methods. [Figure 13B] Compare non-singlet exclusion and singlet preservation between the different methods. [Figure 14A] The clustering results are presented. [Figure 14B] The clustering results are presented. [Figure 15] Box plots of singlet inclusion and non-singlet exclusion are shown. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0013] Computer-implemented methods for classifying analyte data are provided. The subject methods include applying a regression model to determine a relationship between an initial set of analyte features and a cluster criterion, generating a sparse set from at most a portion of the initial set of analyte features based on the relationship, generating a classification model based on the sparse set, and applying the classification model to classify the analyte data into clusters. Systems and non-transitory computer-readable storage media configured to perform the subject methods are also provided.

[0014] Before the present disclosure is described in more detail, it is to be understood that this disclosure is not limited to particular embodiments described, which may, of course, vary. It is also to be understood that the terminology used herein is for the purpose of describing particular embodiments only, and is not intended to be limiting, as the scope of the present disclosure will be limited only by the appended claims.

[0015] Where a range of values ​​is provided, unless the context clearly dictates otherwise, it is to be understood that each intermediate value between the upper and lower limits of that range, to the tenth of the unit of the lower limit, and any other stated or intermediate value within this stated range, is encompassed in the disclosure. The upper and lower limits of these smaller ranges may independently be included in the smaller ranges, and are also encompassed within the disclosure, subject to any specific excluded limit in the stated range. Where a stated range includes one or both of the limits, ranges excluding either or both of those included limits are also included in the disclosure.

[0016] Certain ranges are presented herein with numerical values ​​preceded by the term "about." The term "about" is used herein to provide literal support for the exact number it precedes, as well as a number that is near or approximately the number it precedes. In determining whether a number is near or approximately a specifically recited number, the near or approximately unrecited number may be a number that provides the substantial equivalence of the specifically recited number in the context presented.

[0017] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this disclosure belongs. In addition, any methods and materials similar or equivalent to those described herein can be used in the practice or testing of this disclosure, but representative illustrative methods and materials are described below.

[0018] All publications and patents cited herein are incorporated by reference as if each individual publication or patent was specifically and individually indicated to be incorporated by reference, and are incorporated by reference herein to disclose and describe the methods and / or materials in connection with which the publications are cited. The citation of any publication is for its disclosure prior to the filing date and should not be construed as an admission that the present disclosure is not entitled to antedate such publication by virtue of prior disclosure. Further, the dates of publication provided may be different from the actual publication dates which may need to be independently confirmed.

[0019] It should be noted that, as used in this specification and the appended claims, the singular forms "a," "an," and "the" include plural referents unless the context clearly indicates otherwise. It should be further noted that the claims may be drafted to exclude any optional element. As such, this statement is intended to serve as a predicate to the use of such exclusive terminology, such as "solely," "only," or the use of a "negative" limitation in connection with the recitation of claim elements.

[0020] As will be apparent to those skilled in the art upon reading this disclosure, each of the individual embodiments described and illustrated herein has individual elements and features which may be readily separated from or combined with the features of any of the other several embodiments without departing from the scope or spirit of the disclosure. Any recited method may be carried out in the order of events recited or in any other order which is logically possible.

[0021] Although the systems and methods have been described or will be described for grammatical fluidity with functional descriptions, it is expressly understood that the claims, unless expressly formulated under 35 U.S.C. ...

[0022] Methods for classifying analyte data Aspects of the present disclosure include computer-implemented methods of classifying analyte data into clusters. "Analyte data" refers to data obtained by evaluating a particular analyte for a particular characteristic. "Classifying" analyte data means designating analyte data (e.g., a group of analyte data) as belonging to a particular type among one or more possible different types to which the data may belong. The methods of the present disclosure may, in some cases, be sufficient to improve analyte data classification compared to traditional classification methods, such as when the analyte data is manually classified by a user (e.g., by drawing a gate on the flow cytometer data). For example, the subject methods may, in certain embodiments, increase classification accuracy. Accuracy may be determined by evaluating whether each analyte or data point / event associated therewith actually belongs to the particular type to which it is classified. In certain cases, the methods of the present disclosure may increase classification accuracy by 1% or more, including, for example, 5% or more, such as 10% or more, such as 15% or more and 20% or more, compared to traditional methods (e.g., drawing manual gates). In embodiments, implementing the methods of the present invention is sufficient to increase the speed and / or efficiency with which analyte data is classified, for example, by 5% or more, for example, 10% or more, for example, 1% or more, including 15% or more and 20% or more, compared to conventional methods (e.g., drawing manual gates). As noted above, the methods of the present disclosure are computer-implemented methods. In other words, the method steps described herein may be performed via a processor associated with a computer system. Any suitable processor may be used in the subject methods, such as those described below with respect to the systems of the present disclosure.

[0023] In some cases, the analyte data is flow cytometer data. "Flow cytometer data" refers to information about the characteristics of sample particles that are collected by any number of detectors in a particle analyzer. As discussed herein, a "particle analyzer" is an analytical tool (e.g., a flow cytometer) that allows characterization of particles based on certain (e.g., optical) parameters. "Particle" refers to a discrete component of a biological sample, such as a molecule, an analyte-bound bead, an individual cell, etc. Although the present disclosure is described primarily with respect to flow cytometer data, the applicability of the present disclosure is not limited to flow cytometer data. In certain cases, the present disclosure may be applicable to other types of data, such as nucleic acid data.

[0024] The flow cytometer data may be received from any suitable source. In some embodiments, the flow cytometer data is received from a memory of a storage device. In such embodiments, the flow cytometer data may be pre-generated and stored in the memory of a storage device for subsequent recall and analysis. In other embodiments, the flow cytometer data is received in real-time. Stated differently, the flow cytometer data generated during operation of the flow cytometer may then (e.g., immediately) be populated into a data space (e.g., a two-dimensional plot). In embodiments, the flow cytometer data is received from a forward scatter detector. The forward scatter detector may, in some cases, provide information regarding the overall size of the particle. In embodiments, the flow cytometer data is received from a side scatter detector. In some cases, the side scatter detector is configured to detect diffracted and reflected light from the surface and internal structure of the particle, which tends to increase as the particle structure becomes more complex.

[0025] In certain embodiments, particles are detected and uniquely identified, as needed, by exposing the particles to excitation light and measuring the fluorescence of each particle in one or more detection channels. The fluorescence emitted in the detection channels used to identify the particles and their associated binding complexes can be measured after excitation with a single light source, or can be measured individually after excitation with separate light sources. If separate excitation light sources are used to excite the particle labels, the labels can be selected such that all labels are excitable by each of the excitation light sources used. In embodiments, the flow cytometer data is received from a fluorescence detector. The fluorescence detector can be configured in some cases to detect fluorescent emissions from fluorescent molecules, for example, labeled specific binding members (such as labeled antibodies that specifically bind to markers of interest) associated with the particles in the flow cell. In certain embodiments, the method includes detecting fluorescence from the sample using one or more fluorescence detectors, including, for example, 2 or more, for example, 3 or more, for example, 4 or more, for example, 5 or more, for example, 6 or more, for example, 7 or more, for example, 8 or more, for example, 9 or more, for example, 10 or more, for example, 15 or more, and 25 or more fluorescence detectors. In embodiments, each of the fluorescence detectors is configured to generate a fluorescence data signal. Fluorescence from the sample may be detected by each fluorescence detector independently over one or more of a wavelength range of 200 nm to 1200 nm. In some cases, the method includes detecting fluorescence from the sample over a wavelength range including, for example, 200 nm to 1200 nm, for example, 300 nm to 1100 nm, for example, 400 nm to 1000 nm, for example, 500 nm to 900 nm, and 600 nm to 800 nm. In other cases, the method includes detecting fluorescence using each fluorescence detector at one or more specific wavelengths. For example, fluorescence may be detected at one or more of 450 nm, 518 nm, 519 nm, 561 nm, 578 nm, 605 nm, 607 nm, 625 nm, 650 nm, 660 nm, 667 nm, 670 nm, 668 nm, 695 nm, 710 nm, 723 nm, 780 nm, 785 nm, 647 nm, 617 nm, and any combination thereof, depending on the number of different fluorescence detectors in the subject optical detection system.In certain embodiments, the method includes detecting wavelengths of light that correspond to the fluorescence peak wavelengths of certain fluorophores present in the sample. In embodiments, the flow cytometer data is received from one or more photodetectors (e.g., one or more detection channels), including, for example, two or more, e.g., three or more, e.g., four or more, e.g., five or more, e.g., six or more, and eight or more photodetectors (e.g., eight or more detection channels).

[0026] In some cases, the methods may include classifying multiple sets of analyte data, including, for example, two or more sets, three or more sets, four or more sets, five or more sets, seven or more sets, eight or more sets, nine or more sets, and ten or more sets. In such cases, the sets may be from the same source or from different sources. The number of data points (e.g., events, observations) classified by the subject methods may also vary. In some cases, the number of data points ranges from 1k to 100k, including, for example, from 10k to 80k, e.g., from 20k to 60k, and from 25k to 50k. In some embodiments the number of data points is 1k or more, including, e.g., 5k or more, such as 10k or more, for example 15k or more, such as 20k or more, for example 25k or more, such as 30k or more, for example 35k or more, such as 40k or more, for example 45k or more, such as 50k or more, for example 55k or more, such as 60k or more, for example 65k or more, such as 70k or more, for example 75k or more, such as 80k or more, for example 85k or more, such as 90k or more, for example 95k or more and 100k or more.

[0027] In some cases, prior to clustering the analyte data, the method includes preprocessing the data, e.g., so that the data is in a form more suitable for manipulation by different models. Any suitable preprocessing protocol may be used. In some embodiments, the method includes standardizing the analyte features, e.g., so that they are mean-centered and scaled to unit variance.

[0028] The disclosed method includes applying a regression model to determine a relationship between the initial set of analyte features and the cluster criteria. By "analyte feature" is meant one or more characteristics (e.g., optical, impedance, and / or time characteristics) associated with each individual analyte (e.g., particle) such that each analyte is present in the analyte data as a set of digitized feature values. Depending on the requirements of a given experiment, the number of analyte features present in the data may vary and may include, for example, 10 or more, including 20 or more features, for example, 30 or more features, for example, 40 or more features, for example, 50 or more features, and 60 or more features. In certain cases, the analyte feature is selected from a size feature, an imaging feature, and a scattering feature. In some such cases, the analyte feature is a scattering feature selected from a side scatter (SSC) feature and a forward scatter (FSC) feature. If the analyte data is flow cytometer data, the analyte feature may also be associated with and / or obtained from fluorescence, axial light loss (ALL), and the like. Exemplary features include, but are not limited to, size, center of mass, minor axis moment, diffusivity, major axis moment, radial moment, maximum intensity, and eccentricity. In an embodiment, the analyte feature comprises an imaging feature.

[0029] The "cluster criteria" discussed herein may be any suitable standard by which analyte data may be evaluated and classified into clusters. For example, the cluster criteria may be the association of analyte data with a certain parameter of interest. Analyte data may be considered to be "associated" with a parameter of interest if the analyte corresponding to the data can be said to correspond to the parameter, i.e., if it is positive. Such analyte data may be classified into a particular cluster, while analyte data that does not correspond to the cluster criteria may be classified into one or more other clusters (e.g., clusters that are negative for the parameter of interest). In some embodiments, analyte data that does not correspond to the cluster criteria may be classified into a single cluster (i.e., such that there are two total clusters). Alternatively, analyte data that does not correspond to the cluster criteria may be classified into multiple clusters according to some other criteria, including, for example, two or more clusters, three or more clusters, four or more clusters, five or more clusters, six or more clusters, seven or more clusters, eight or more clusters, nine or more clusters, and ten or more clusters. The cluster criteria may vary depending on the nature of the analyte observed and / or the nature of the experiment being performed. In some cases, the cluster criteria is the association of analyte data with singlets. In such cases, flow cytometer data associated with singlets may be classified into a singlet cluster, while flow cytometer data not associated with singlets may be classified into one or more non-singlet clusters. Non-singlets that may be classified into non-singlet clusters may include, but are not limited to, multiplets / aggregates (e.g., doublets, triplets, quadruplets, quintuplets, etc.), debris (e.g., components of lysed cells), etc. In accordance with the above, non-singlets may be classified into a single non-singlet cluster, or may be further segmented into multiple non-singlet clusters (e.g., one cluster corresponding to doublets and one corresponding to debris, etc., as appropriate). In some cases, a non-singlet cluster includes a doublet or an aggregate.Other cluster criteria may include association with specific fluorescent markers that may themselves be associated with a particular phenotype of the analyte, depending on the nature of the experiment being performed. In some embodiments, the cluster criterion is the size or shape of the analyte.

[0030] The "initial" set of analyte features is a subset of analyte features from a population of possible analyte features (e.g., those that can be obtained from a given flow cytometer in an experiment with certain constraints), which are found to have a relationship to the cluster criteria via the regression model such that the initial set is more useful for predicting the classification of analyte data into clusters according to the cluster criteria compared to other analyte features in the population of possible analyte features. In some cases, the analyte features in the initial set are more predictive than the population of possible analyte features when considered as including 1% or more, such as 5% or more, such as 10% or more, such as 15% or more, such as 20% or more, such as 25% or more, such as 30% or more, such as 35% or more, such as 40% or more, and 50% or more as a whole. The regression model can be any model configured to estimate a relationship between the analyte features and the cluster criteria. In some cases, the regression model uses linear regression. In other cases, the regression model uses non-linear regression. Regression models may include, for example, Bayesian methods, percentage regression, scenario optimization, least absolute deviations, non-parametric regression, scenario optimization, distance metric learning, and the like, in some cases.

[0031] The number of analyte features in the initial set can vary. In some cases, the initial set of analyte features includes 5-20 analyte features, such as 7-15 analyte features, 9-11 analyte features, etc. In some cases, the initial set of analyte features includes 5 analyte features, 6 analyte features, 7 analyte features, 8 analyte features, 9 analyte features, 10 analyte features, 11 analyte features, 12 analyte features, 13 analyte features, 14 analyte features, 15 analyte features, 16 analyte features, 17 analyte features, 18 analyte features, 19 analyte features, or 20 analyte features. The number of analyte features can also be described as a percentage of the number of analyte features in a population of possible analyte features. In some cases, the initial set of analyte features comprises 10% or more of the possible analyte features, including, for example, 11% or more, 12% or more, 13% or more, 14% or more, 15% or more, 16% or more, 17% or more, 18% or more, 19% or more, 20% or more, 21% or more, 22% or more, 23% or more, 24% or more, and 25% or more. In some embodiments, the initial set includes both imaged and non-imaged analyte features.

[0032] The disclosed method further includes generating a sparse set from at most a portion of the initial set of analyte features based on the relationship. By "sparse set" is meant a subset of the initial set of analyte features that is further refined based on predictiveness for the cluster criteria. In other words, the sparse set optimizes the proportion of inclusion from the cluster of analyte data (e.g., singlets) associated with the cluster criteria and the proportion of exclusion of analyte data (e.g., non-singlets) not associated with the cluster criteria. The number of analyte features in the sparse set may vary in some cases and may range from 2 to 10 analyte features, such as including 2 to 5 analyte features and 2 to 4 analyte features. In some cases, the sparse set includes 2 analyte features, 3 analyte features, 4 analyte features, 5 analyte features, 6 analyte features, 7 analyte features, 8 analyte features, 9 analyte features, or 10 analyte features. In some cases, the sparse set includes 10% or more of the analyte features from the initial set, including, e.g., 15% or more, e.g., 20% or more, e.g., 25% or more, e.g., 30% or more, 35% or more, and 40% or more.

[0033] The protocol by which the sparse set is generated varies in some cases. In some instances, generating a sparse set of analyte features includes iteratively tuning an initial set of analyte features. In embodiments, the iterative tuning involves estimating experimental inclusion and exclusion rates for a cluster criterion. Stated differently, the iterative tuning involves estimating the true inclusion rate of analyte data in a cluster associated with the cluster criterion, and the exclusion of analyte data not associated with the cluster criterion from the same cluster. In a particular example involving singlets and non-singlets, the iterative tuning involves estimating the experimental true singlet inclusion rate and true non-singlet exclusion rate. The tuning may be repeated until an optimal rate is found. In some cases, generating a sparse set involves iteratively testing different combinations of analyte features for accuracy (e.g., with respect to true singlet inclusion rate and true non-singlet exclusion rate), and the combination with the highest accuracy is deemed optimal. In some embodiments, the sparse set includes both imaged and non-imaged analyte features.

[0034] In embodiments, the sparse set of analyte features may be generated based on training data. In some cases, the training data is used during application of the regression model, iterative tuning, or both. The training data may be received from any suitable source. In some embodiments, the training data is received from a memory of a storage device. In such embodiments, the training data may be pre-generated and stored in a memory of a storage device for subsequent recall and analysis. In embodiments, the analyte data in the training dataset are of known classification. For example, in some cases where the training dataset includes flow cytometer data, each individual analyte may be confirmed to correspond to one class or another by some other means. In certain cases, an expert user manually provides classifications to the training dataset. This may include, for example, manually drawing gates on a two-dimensional plot of the flow cytometer data. Analyte features from the training dataset, as well as their classifications, may be provided for training purposes. In other words, the training data may be considered "ground truth" data. In some versions, such ground truth data is obtained by using specific stains or dyes in flow cytometer experiments that are known to correspond to analyte properties of interest. The stain or dye may be selected depending on the nature of the feature. For example, if it is desired to cluster singlets and non-singlets, ground truth data may be obtained using a DNA intercalating dye. Cells (at least eukaryotic varieties) generally have a single nucleus that contains DNA. Thus, by staining the DNA, the user can reliably determine whether a given event / observation involves one cell (i.e., a singlet) or multiple cells (i.e., a non-singlet). DNA intercalating dyes that may be used include, but are not limited to, ethidium bromide, SYBR green, propidium iodide, acridine orange, DAPI, and DRAQ5.In some embodiments, the method includes training using multiple training datasets, including, for example, two or more training datasets, e.g., three or more training datasets, e.g., four or more training datasets, and five or more training datasets.

[0035] In addition to the above, the method includes generating a classification model based on the sparse set. Any classification model suitable for clustering analyte data may be used. In some cases, the classification model is a machine learning algorithm. In some versions, the classification model is or includes a mixture model. A mixture model represents a combination of probability distributions. Each distribution may be a different subgroup or cluster in the data. These component distributions may be of different types, such as Gaussian (normal distribution), exponential distribution, or other, depending on the nature of the data being modeled. In a mixture model, each data point is assumed to have been generated by one of the component distributions, with the likelihood of being generated by each component determined by the parameters of the model. The parameters typically include the weights (or proportions) of each component and the parameters of each component distribution (e.g., mean (μ), covariance (Σ)). More details regarding mixture models may be found, for example, in McNicholas, PD (2016), Mixture Model-Based Classification, incorporated herein by reference.

[0036] In certain embodiments, the mixture model comprises a Gaussian mixture model. In such embodiments, the method involves assuming that the analyte data comprises a mixture of Gaussian distributions (i.e., Gaussian distributions). In one exemplary version, the method comprises: c , covariance Σ c , and the proportion per cluster Π c and calculating the probability that each data point in the analyte data belongs to cluster c as follows:

[0037]

number

[0038] where N(x|μ,Σ) describes the multivariate Gaussian:

[0039]

number

[0040] For each cluster c, the method calculates the total weight m c and the parameter mean μ c , covariance Σ c , and the proportion per cluster Π c The probability that each data point belongs to cluster c may be calculated using the following formula:

[0041]

number

[0042] The method according to some embodiments also includes iteratively repeating the above steps until a log-likelihood function of the model:

[0043]

number

[0044] Thus, each data point is assigned to a cluster.

[0045] In some cases, the classification model includes a density-based spatial clustering for applications with noise (DBSCAN) algorithm. DBSCAN groups data points by density, with points with higher density forming clusters. Details regarding DBSCAN can be found, for example, in Ester et al. (1996) Proceedings of the Second International Conference on Knowledge Discovery and Data. 96(34):226-231, incorporated herein by reference. In some cases, the classification model includes a K-means clustering algorithm. K-means clustering involves dividing observations into clusters where each observation belongs to the cluster with the closest mean (e.g., centroid). Details regarding K-means clustering can be found, for example, in Lloyd, Stuart P. (1967) IEEE Transactions on Information Theory. 28(2):129-137, incorporated herein by reference. In other cases, the classification model includes a balanced iterative reduction and clustering using hierarchies (BIRCH) algorithm. BIRCH is an unsupervised data mining algorithm used for hierarchical clustering. Details regarding BIRCH can be found, for example, in Zhang et al. (1996) ACM sigmod record. 25(2):103-114. In certain implementations, BIRCH can be used to complement one or more of the other algorithms discussed herein. For example, in some embodiments, BIRCH is used to accelerate K-means clustering. In further embodiments, BIRCH is used to accelerate Gaussian mixture modeling as described herein. In certain versions, the classification model includes a spectral clustering algorithm. Spectral clustering involves the use of eigenvalues ​​of a similarity matrix.More details regarding spectral clustering can be found, for example, in Von Luxburg, U. (2007) Statistics and computing 17: 395-416, incorporated herein by reference.

[0046] After the classification model is generated, the method of the present disclosure includes applying the classification model to classify the analyte data into clusters. Following classification of the analyte data, the method according to some versions may include evaluating the classification model, for example, by comparing the classification to ground truth data. In some cases, classifying the analyte data via the methods described herein includes including 90% or more of the analyte data associated with the cluster criteria in a cluster associated with the cluster criteria, for example, including 90% or more and 97% or more. Additionally, classifying the analyte data via the methods described herein may involve excluding 85% or more of the analyte data not associated with the cluster criteria from a cluster associated with the cluster criteria, for example, including 90% or more and 92% or more. In some embodiments, the method includes generating one or more population clusters based on analyte features within the sample. As used herein, a "population" or "subpopulation" of analytes, such as cells, nucleic acids, or other particles, generally refers to a group of analytes that possess characteristics (e.g., optical properties, impedance properties, time properties, etc.) with respect to one or more measured parameters such that the measured parameter data form a cluster in the data space. In embodiments, the data is composed of signals from any given number of different parameters, including, for example, 2 or more, 3 or more, 4 or more, 5 or more, 6 or more, 7 or more, 8 or more, 9 or more, 10 or more, and 20 or more. Thus, populations are recognized as clusters in the data. Each data cluster is generally interpreted as corresponding to a population of a particular type of cell or analyte, although conversely, clusters corresponding to noise or background are also typically observed. Clusters can be defined in terms of a subset of measured parameters that correspond to populations that differ only within a subset of dimensions, for example, within a subset of measured parameters or features extracted from measurements of cells, particles, or nucleic acids.

[0047] In an embodiment, the method includes receiving data, calculating a parameter for each analyte, and clustering the analytes together based on the calculated parameters. For example, if the data is flow cytometer data, the experiment may include particles labeled with several fluorophores or fluorescently labeled antibodies, and groups of particles may be defined by populations corresponding to one or more fluorescence measurements. In an example, a first group may be defined by a range of light scattering for a first fluorophore, and a second group may be defined by a range of light scattering for a second fluorophore. If the first and second fluorophores are represented on the x-axis and y-axis, respectively, when the information is displayed graphically, two different color-coded populations may be displayed defining each group of particles. Any number of analytes may be assigned to a cluster including 5 or more analytes, including, for example, 10 or more analytes, for example, 50 or more analytes, for example, 100 or more analytes, for example, 500 or more analytes, and 1000 or more analytes. In certain embodiments, the method groups rare events detected in the sample (e.g., rare cells in the sample, such as cancer cells) together in a cluster. In these embodiments, the analyte clusters generated may include, for example, 10 or fewer assigned analytes, including 9 or fewer and 5 or fewer assigned analytes.

[0048] FIG. 1 presents a flowchart for practicing a method according to an embodiment of the present disclosure. As shown in FIG. 1, step 101 involves applying a regression model to determine a relationship between an initial set of analyte features and a cluster criterion. Step 102 involves generating a sparse set from at most a portion of the initial set of analyte features based on the relationship. Step 103 involves generating a classification model based on the sparse set. Step 104 involves applying the classification model to classify the analyte data into clusters.

[0049] In certain cases, the methods of the present disclosure may be practiced in conjunction with the methods described in U.S. Provisional Patent Application No. 63 / 569,559, filed March 25, 2024 (Atty. Dkt. No. BECT-367PRV), the disclosure of which is incorporated herein by reference in its entirety. In such cases, the computer-implemented method may include classifying the analyte data based on an analyte feature associated therewith by generating a predicted class of the analyte data using a decision tree ensemble, and refining the classified analyte data based on the analyte feature and the predicted class to classify the analyte data using a distance-based classification model.

[0050] In some cases, the sample analyzed in the present method is a biological sample. The term "biological sample" is used in its conventional sense to refer to a whole organism, a plant, a fungus, or a subset of animal tissues, cells, or components that may be found in certain cases, blood, mucus, lymph, synovial fluid, cerebrospinal fluid, saliva, bronchoalveolar lavage, amniotic fluid, amniotic cord blood, urine, vaginal fluid, and semen. Thus, a "biological sample" refers to both a natural organism or a subset of its tissues, as well as homogenates, lysates, or extracts prepared from an organism or a subset of its tissues, including, but not limited to, for example, plasma, serum, spinal fluid, lymph, skin sections, respiratory tract, gastrointestinal tract, cardiovascular, and urinary tract, tears, saliva, milk, blood cells, tumors, organs. A biological sample can be any type of biological tissue, including both healthy and diseased tissue (e.g., cancerous, malignant, necrotic, etc.). In certain embodiments, the biological sample is a liquid sample such as blood or a derivative thereof, e.g., plasma, tears, urine, semen, etc., and in some cases the sample is a blood sample, including whole blood, such as blood obtained from a venipuncture or fingerstick (which may or may not be combined with any reagents, such as preservatives, anticoagulants, etc., prior to assay).

[0051] In certain embodiments, the sample source is a "mammal" or "mammalian animal," terms used broadly to describe organisms within mammals, including carnivores (e.g., dogs and cats), rodents (e.g., mice, guinea pigs, and rats), and primates (e.g., humans, chimpanzees, and monkeys). In some cases, the subject is a human. The methods may be applied to samples obtained from human subjects of both genders, at any stage of development (i.e., neonates, infants, juveniles, adolescents, adults), and in certain embodiments, the human subjects are juveniles, adolescents, or adults. It is understood that the present disclosure may be applied to samples from human subjects, but may also be practiced on samples from other animal subjects (i.e., "non-human subjects"), such as, but not limited to, birds, mice, rats, dogs, cats, livestock, and horses.

[0052] Cells of interest may be targeted for characterization according to various parameters, such as phenotypic characteristics identified via attachment of specific fluorescent labels to the cells of interest. In some embodiments, the system is configured to deflect analyzed droplets determined to contain target cells. A variety of cells may be characterized using the subject methods. Target cells of interest include, but are not limited to, stem cells, T cells, dendritic cells, B cells, granulocytes, leukemia cells, lymphoma cells, viral cells (e.g., HIV cells), NK cells, macrophages, monocytes, fibroblasts, epithelial cells, endothelial cells, and red blood cells. Target cells of interest include cells that have a favorable cell surface marker or cell surface antigen that can be captured or labeled by a favorable affinity agent or complex thereof. For example, target cells may comprise cell surface antigens such as CD11b, CD123, CD14, CD15, CD16, CD19, CD193, CD2, CD25, CD27, CD3, CD335, CD36, CD4, CD43, CD45RO, CD56, CD61, CD7, CD8, CD34, CD1c, CD23, CD304, CD235a, T cell receptor alpha / beta, T cell receptor gamma / delta, CD253, CD95, CD20, CD105, CD117, CD120b, Notch4, Lgr5 (N-terminus), SSEA-3, TRA-1-60 antigen, disialoganglioside GD2, and CD71. In some embodiments, the target cells are selected from HIV-containing cells from whole blood, bone marrow or umbilical cord blood, Treg cells, antigen-specific T cell populations, tumor cells, or hematopoietic progenitor cells (CD34+).

[0053] In practicing the subject methods, a volume of an initial fluid sample is injected into a flow cytometer. The volume of sample injected into the particle sorting module can vary from 0.001 mL to 1000 mL, including, for example, 0.005 mL to 900 mL, e.g., 0.01 mL to 800 mL, e.g., 0.05 mL to 700 mL, e.g., 0.1 mL to 600 mL, e.g., 0.5 mL to 500 mL, e.g., 1 mL to 400 mL, e.g., 2 mL to 300 mL, and 5 mL to 100 mL of sample.

[0054] Methods according to embodiments of the present disclosure include counting and optionally sorting labeled particles (e.g., target cells) in a sample. In practicing the subject method, a fluid sample containing particles is first introduced into a flow nozzle of the system. Upon exiting the flow nozzle, the particles pass substantially one-by-one through a sample inspection region where each of the particles is illuminated by a light source, and in some cases, light scattering parameters and fluorescence emission measurements (e.g., two or more light scattering parameters and one or more fluorescence emission measurements) are recorded separately for each particle as needed. Depending on the characteristics of the flow stream being inspected, 0.001 mm or more of the flow stream may be illuminated with light, including, for example, 0.005 mm or more, such as 0.01 mm or more, such as 0.05 mm or more, such as 0.1 mm or more, such as 0.5 mm or more, and 1 mm or more of the flow stream may be illuminated with light. In certain embodiments, the method includes illuminating a planar cross-section of the flow stream in the sample inspection region, such as with a laser (as described above). In another embodiment, the method includes irradiating a predetermined length of the flow stream within the specimen inspection region, for example, corresponding to an illumination profile of a diffuse laser beam or lamp.

[0055] In certain embodiments, the method includes irradiating the flow stream at or near the flow cell nozzle orifice. For example, the method can include irradiating the flow stream at about 0.001 mm or more from the nozzle orifice, including, for example, 0.005 mm or more, such as 0.01 mm or more, such as 0.05 mm or more, such as 0.1 mm or more, such as 0.5 mm or more, and 1 mm or more from the nozzle orifice. In certain embodiments, the method includes irradiating the flow stream directly adjacent to the flow cell nozzle orifice.

[0056] In an embodiment of the method, detectors such as photomultiplier tubes (PMTs) are used to record the light passing through each particle as it passes through the sensing region and is illuminated by an energy source (in certain cases referred to as forward light scatter), the light reflected perpendicular to the direction of flow of the particle through the sensing region (sometimes referred to as orthogonal or side light scatter), and the fluorescence emitted from the particle if it is labeled with a fluorescent marker. Each of the forward light scatter (FSC), side-scatter (SSC), and fluorescent emission comprises a separate parameter for each particle (or each "event"). Thus, for example, two, three, or four parameters may be collected (and recorded) from a particle labeled with two different fluorescent markers. The data recorded for each particle is analyzed in real time or stored in a data storage and analysis means such as a computer, as required.

[0057] In certain embodiments, particles are optionally detected and uniquely identified by exposing the particles to excitation light and measuring the fluorescence of each particle in one or more detection channels. The fluorescence emitted in the detection channels used to identify the particles and their associated binding complexes can be measured after excitation with a single light source, or can be measured individually after excitation with separate light sources. When separate excitation light sources are used to excite the particle labels, the labels can be selected such that all labels are excitable by each of the excitation light sources used.

[0058] The method in certain embodiments also includes acquiring, analyzing, and recording data, such as with a computer, where multiple data channels record data from each detector for light scattering and fluorescence emitted by each particle as it passes through the sample inspection area of ​​the particle sorting module. In these embodiments, the analysis includes sorting and counting the particles, such that each particle exists as a set of digitized parameter values. The subject system can be set to trigger on selected parameters to distinguish particles of interest from background and noise. "Trigger" refers to a pre-set threshold for detecting a parameter and can be used as a means to detect the passage of a particle through a light source. Detection of an event exceeding the threshold of the selected parameter triggers the acquisition of light scattering and fluorescence data of the particle. Data is not acquired for particles or other components in the medium being analyzed that cause a response below the threshold. The trigger parameter can be detection of forward scattered light caused by a particle passing through a light beam. The flow cytometer then detects and collects the light scattering and fluorescence data of the particle.

[0059] The particular subpopulation of interest is then further analyzed by "gating" based on the data collected for the entire population. To select the appropriate gate, the data is plotted to obtain the best possible separation of the subpopulations. This procedure can be performed by plotting forward light scatter (FSC) versus side (i.e., orthogonal) light scatter (SSC) on a two-dimensional dot plot. A subpopulation of particles (i.e., those cells within the gate) is then selected, and particles not within the gate are excluded. If desired, a gate can be selected by drawing a line around the desired subpopulation using a cursor on the computer screen. Then, only those particles within the gate are further analyzed by plotting other parameters of these particles, such as, for example, fluorescence. If desired, the above analysis can be configured to result in a count of particles of interest in the sample.

[0060] The subject methods may further include using the particles in research, laboratory testing, or therapy. In some embodiments, the subject methods include obtaining individual cells prepared from a target fluid or tissue biosample. For example, the subject methods include obtaining cells from a fluid or tissue sample that is used as a research or diagnostic specimen for a disease such as cancer. Similarly, the subject methods include obtaining cells from a fluid or tissue sample that is used for therapy. Cell therapy protocols are protocols in which viable cellular material, including, for example, cells and tissue, may be prepared and introduced into a subject as a therapeutic treatment. Conditions that may be treated by administration of flow cytometrically sorted samples include, but are not limited to, blood disorders, immune system disorders, organ damage, and the like.

[0061] A typical cell therapy protocol may include steps of sample collection, cell isolation, genetic modification, culture, and in vitro expansion, cell harvesting, sample volume reduction and washing, biopreservation, storage, and introduction of cells into a subject. The protocol may begin with the collection of viable cells and tissues from a source tissue of a subject to generate a cell and / or tissue sample. The sample may be collected via any suitable procedure, including, for example, administering a cell mobilizing agent to the subject, drawing blood from the subject, removing bone marrow from the subject, and the like. After collecting the sample, cell enrichment may occur via several methods, including, for example, centrifugation-based methods, filter-based methods, elution, magnetic separation methods, fluorescence-activated cell sorting (FACS), and the like. In some cases, the enriched cells may be genetically modified by any convenient method, for example, nuclease-mediated gene editing. The genetically modified cells may be cultured, activated, and expanded in vitro. In some cases, the cells are preserved, e.g., cryopreserved, and retained for future use, whereupon the cells are thawed and then administered to a patient, e.g., the cells may be infused into the patient.

[0062] system Aspects of the present disclosure also include systems, including a memory operatively coupled to a processor, the memory including instructions stored in the memory that, when executed by the processor, cause the processor to perform a method of the present disclosure, i.e., applying a regression model to determine a relationship between an initial set of analyte features and a cluster criterion, generating a sparse set from at most a portion of the initial set of analyte features based on the relationship, generating a classification model based on the sparse set, and applying the classification model to classify the analyte data into clusters.

[0063] The system may include a display and an operator input device. The operator input device may be, for example, a keyboard, a mouse, etc. The processing module includes a processor that accesses a memory having instructions stored therein to perform the steps of the subject method. The processing module may include an operating system, a graphical user interface (GUI) controller, a system memory, a memory storage device, and an input / output controller, a cache memory, a data backup unit, and many other devices. The processor may be a commercially available processor or one of other processors that are available or that become available. The processor executes an operating system, which interfaces with firmware and hardware in a well-known manner to facilitate the processor's coordination and execution of functions of various computer programs, which may be written in various programming languages, such as Java, Perl, C++, Python, other high-level or low-level languages, and combinations thereof, as is known in the art. The operating system typically cooperates with the processor to coordinate and execute the functions of the other components of the computer. The operating system also provides scheduling, input / output control, file and data management, memory management, and communication control and related services, all in accordance with known techniques. In some embodiments, the processor includes analog electronics that provide feedback control, such as, for example, negative feedback control.

[0064] The system memory can be any of a variety of known or future memory storage devices. Examples include any commonly available random access memory (RAM), magnetic media such as a resident hard disk or tape, optical media such as a read-write compact disk, flash memory devices, or other memory storage devices. The memory storage device can be any of a variety of known or future devices, including a compact disk drive, tape drive, or disk drive. Such types of memory storage devices typically read from and / or write to a program storage medium (not shown), such as a compact disk. Any of these program storage media, or others now in use or that may later be developed, may be considered a computer program product. As will be appreciated, these program storage media typically store computer software programs and / or data. Computer software programs, also referred to as computer control logic, are typically stored in the system memory and / or in program storage devices used in conjunction with the memory storage devices.

[0065] In some embodiments, a computer program product is described that comprises a computer usable medium having stored thereon control logic (a computer software program including program code). The control logic, when executed by a processor of the computer, causes the processor to perform the functions described herein. In other embodiments, some functions are implemented primarily in hardware, for example, using hardware state machines. Implementations of hardware state machines to perform the functions described herein will be apparent to those skilled in the relevant art.

[0066] The subject programmable logic may be implemented in any of a variety of devices, such as a specially programmed event processing computer, a wireless communication device, or an integrated circuit device. In some embodiments, the programmable logic may be executed by a specially programmed processor, which may include one or more processors, such as one or more digital signal processors (DSPs), configurable microprocessors, application specific integrated circuits (ASICs), field programmable gate arrays (FPGAs), or other equivalent integrated or discrete logic circuits. Combinations of computing devices, such as a combination of a DSP and a microprocessor, multiple microprocessors, one or more microprocessors in conjunction with a DSP core, or any other such configuration in at least partial data connectivity, may implement one or more of the features described herein.

[0067] The memory may be any suitable device from which the processor can store and retrieve data, such as a magnetic, optical, or solid-state storage device (including a magnetic or optical disk, or tape, or RAM, or any other suitable device, either fixed or portable). The processor may include a general-purpose digital microprocessor suitably programmed from a computer-readable medium carrying the necessary program code. The programming may be provided remotely to the processor over a communication channel, or may be pre-stored in a computer program product, such as a memory or some other portable or fixed computer-readable storage medium, using any of those devices together with the memory. For example, a magnetic or optical disk may carry the programming and can be read by a disk writer / reader. The system of the present disclosure also includes programming, for example in the form of a computer program product, algorithms for use in implementing the above-described methods. The programming according to the present disclosure may be recorded on a computer-readable medium, for example, any medium that can be directly read and accessed by a computer. Such media include, but are not limited to, magnetic storage media such as floppy disks, hard disk storage media, and magnetic tape, optical storage media such as CD-ROMs, electrical storage media such as RAM and ROM, portable flash drives, and hybrids of these categories such as magnetic / optical storage media.

[0068] The processor may also have access to a communication channel for communicating with a user at a remote location, meaning that the user does not have direct contact with the system, but rather relays input information to the input manager from an external device, such as a computer connected to a wide area network ("WAN"), a telephone network, a satellite network, or any other suitable communication channel, including a cellular phone (i.e., a smartphone).

[0069] In some embodiments, a system according to the present disclosure may be configured to include a communication interface. In some embodiments, the communication interface includes a receiver and / or a transmitter for communicating with a network and / or another device. The communication interface may be configured for wired or wireless communication, including, but not limited to, radio frequency (RF) communication (e.g., radio frequency identification (RFID), ZigBee communication protocol, Wi-Fi, infrared, wireless universal serial bus (USB), ultra-wideband (UWB), Bluetooth® communication protocol, and cellular communication, such as Code Division Multiple Access (CDMA) or Global System for Mobile Communications (GSM).

[0070] In one embodiment, the communications interface is configured to include one or more communications ports, e.g., a physical port or interface such as a USB port, a USB-C port, an RS-232 port, or any other suitable electrical connection port, to enable data communications between the subject system and other external devices, such as computer terminals (e.g., in a clinic or hospital environment) configured for similar complementary data communications.

[0071] In one embodiment, the communications interface is configured for infrared communications, Bluetooth® communications, or any other suitable wireless communications protocol to enable the subject system to communicate with other devices, such as a computer terminal and / or network, a communications-enabled mobile phone, a personal digital assistant, or any other communications device that a user may use in conjunction with.

[0072] In one embodiment, the communication interface is configured to provide a connection for data transfer utilizing the Internet Protocol (IP) via a cellular network, Short Message Service (SMS), a wireless connection to a personal computer (PC) on a local area network (LAN) connected to the Internet, or a Wi-Fi connection to the Internet at a Wi-Fi hotspot.

[0073] In one embodiment, the subject system is configured to communicate wirelessly with the server device via a communications interface using common standards such as, for example, 802.11 or Bluetooth RF protocols, or the IrDA infrared protocol. The server device may be another portable device, such as a smartphone, a personal digital assistant (PDA) or a notebook computer, or a larger device, such as a desktop computer, an appliance, etc. In some embodiments, the server device has a display, such as a liquid crystal display (LCD), and input devices, such as buttons, a keyboard, a mouse, or a touch screen.

[0074] In some embodiments, the communications interface is configured to automatically or semi-automatically communicate data stored within the subject system, e.g., in the optional data storage unit, with a network or server device using one or more of the communications protocols and / or mechanisms described above.

[0075] The output controller may include a controller for any of a variety of known display devices for presenting information to a user, whether human or machine, local or remote. Where one of the display devices provides visual information, this information may typically be logically and / or physically organized as an array of pixels. A graphical user interface (GUI) controller may include any of a variety of known or future software programs for providing a graphical input and output interface between the system and the user, and for processing user input. The functional elements of the computer may communicate with each other via a system bus. Some of these communications may be accomplished in alternative embodiments using a network or other type of remote communication. The output manager may also provide information generated by the processing module to a user at a remote location, for example, via the Internet, telephone, or satellite network, in accordance with known techniques. Presentation of data by the output manager may be performed in accordance with a variety of known techniques. As some examples, the data may include SQL, HTML, or XML documents, emails or other files, or other forms of data. The data may include Internet URL addresses to allow the user to retrieve additional SQL, HTML, XML, or other documents or data from remote sources. The one or more platforms present in the subject system will typically be of a class of computers commonly referred to as servers, but may be any type of known or future developed computer platform. However, they may also be mainframe computers, workstations, or other computer types. They may be connected via any known or future type of cabling or other communication systems, including wireless systems, either networked or not. They may be co-located or physically separated.In some cases, various operating systems may be used on any of the computer platforms, depending on the type and / or configuration of the computer platform selected. Suitable operating systems include Windows NT, Windows XP, Windows 7, Windows 8, Windows 10, iOS, macOS, Linux, Ubuntu, Fedora, OS / 400, i5 / OS, IBM i, Android™, SGI IRIX, Oracle Solaris, and the like.

[0076] In an embodiment, the system further comprises a flow cytometer operatively connected to the processor. The subject flow cytometer generally includes a flow cell. The subject flow cells include a cuvette configured to transport particles in a flow stream. As discussed herein, a "flow cell" is described in its conventional sense to refer to a component that includes a flow channel of a liquid flow stream for transporting particles in a sheath fluid. The subject cuvette has a passageway (i.e., a flow channel) flowing therethrough. The flow stream of which the flow channel is configured may include a liquid sample injected from a sample tube. In certain instances, the flow cell includes an optically accessible flow channel. The cuvette may be constructed, for example, of quartz, glass, clear plastic, or the like. In some embodiments, the cuvette is formed from silica, such as fused silica. In some cases, the flow cell is configured to be illuminated with light from a light source at one or more inspection points. As discussed herein, an "inspection point" refers to an area in the flow cell where particles are illuminated by light from a light source, for example, for analysis. The size of the inspection point may vary as desired. For example, if 0 μm represents the axis of the light emitted by the light source, the inspection points may range from -50 μm to 50 μm, including, for example, from -25 μm to 40 μm, and from -15 μm to 30 μm. Depending on certain considerations (e.g., the number and placement of lasers), multiple illumination points may be present within the flow cell.

[0077] In some embodiments, the flow cell includes or is configured to use a sample injection port configured to provide a sample to the flow cell, hi embodiments, the sample injection system is configured to provide a suitable flow of the sample to the flow cell interior chamber (i.e., flow channel). Depending on the desired characteristics of the flow stream, the rate of sample delivered by the sample injection port to the flow cell chamber may be 1 μL / min or more, including 2 μL / min or more, such as 3 μL / min or more, such as 5 μL / min or more, such as 10 μL / min or more, such as 15 μL / min or more, such as 25 μL / min or more, such as 50 μL / min or more, and 100 μL / min or more, and in some cases the rate of sample delivered by the sample injection port to the flow cell chamber is 1 μL / sec or more, including 2 μL / sec or more, such as 3 μL / sec or more, such as 5 μL / sec or more, such as 10 μL / sec or more, such as 15 μL / sec or more, such as 25 μL / sec or more, such as 50 μL / sec or more, and 100 μL / sec or more.

[0078] The sample injection port may be an orifice located in the wall of the internal chamber or may be a conduit located at the proximal end of the internal chamber. When the sample injection port is an orifice located in the wall of the internal chamber, the sample injection port orifice may be of any suitable shape, including, but not limited to, rectilinear cross-sectional shapes, such as square, rectangular, trapezoidal, triangular, hexagonal, curvilinear cross-sectional shapes, such as circular, elliptical, and irregular shapes, such as a parabolic bottom portion joined to a planar top portion. In certain embodiments, the sample injection port has a circular orifice. The size of the sample injection port orifice may vary depending on the shape, and in certain cases has an opening ranging from 0.1 mm to 5.0 mm, including, for example, 0.2 to 3.0 mm, such as 0.5 mm to 2.5 mm, such as 0.75 mm to 2.25 mm, such as 1 mm to 2 mm, and 1.25 mm to 1.75 mm, such as 1.5 mm.

[0079] In certain cases, the sample injection port is a conduit located at the proximal end of the flow cell internal chamber. For example, the sample injection port may be a conduit arranged to have the orifice of the sample injection port aligned with the flow cell orifice. When the sample injection port is a conduit arranged along the flow cell orifice, the cross-sectional shape of the sample injection tube may be any suitable shape, including, but not limited to, rectilinear cross-sectional shapes, such as square, rectangular, trapezoidal, triangular, hexagonal, curvilinear cross-sectional shapes, such as circular, elliptical, and irregular shapes, such as a parabolic bottom portion joined to a planar top portion. The orifice of the conduit may vary depending on the shape, and in certain cases has an opening ranging from 0.1 mm to 5.0 mm, including, for example, 0.2 to 3.0 mm, such as 0.5 mm to 2.5 mm, such as 0.75 mm to 2.25 mm, such as 1 mm to 2 mm, and 1.25 mm to 1.75 mm, such as 1.5 mm. The shape of the tip of the sample injection port may be the same as or different from the cross-sectional shape of the sample injection tube. For example, the orifice of the sample injection port may include a beveled tip having a bevel angle in the range of 1° to 10°, including bevel angles of, for example, 2° to 9°, such as, for example, 3° to 8°, such as, for example, 4° to 7°, and 5°.

[0080] In some embodiments, the flow cell also includes a sheath fluid injection port configured to provide a sheath fluid to the flow cell. In embodiments, the sheath fluid injection system is configured to provide a flow of sheath fluid to the flow cell interior chamber, e.g., in conjunction with the sample, to generate a laminated flow stream of sheath fluid surrounding the sample flow stream. Depending on the desired characteristics of the flow stream, the velocity of the sheath fluid delivered to the flow cell chamber can be, e.g., 50 μL / sec or more, e.g., 75 μL / sec or more, e.g., 100 μL / sec or more, e.g., 250 μL / sec or more, e.g., 500 μL / sec or more, e.g., 750 μL / sec or more, e.g., 25 μL / sec or more, including 1000 μL / sec or more and 2500 μL / sec or more.

[0081] In some embodiments, the sheath fluid injection port is an orifice located in the wall of the internal chamber. The sheath fluid injection port orifice may be of any suitable shape, including, but not limited to, rectilinear cross-sectional shapes, such as, for example, square, rectangular, trapezoidal, triangular, hexagonal, curvilinear cross-sectional shapes, such as, for example, circular, elliptical, and irregular shapes, such as, for example, a parabolic bottom joined to a planar top. The size of the sheath fluid injection port orifice may vary depending on the shape, and in certain cases has an opening ranging from 0.1 mm to 5.0 mm, including, for example, 0.2 mm to 3.0 mm, such as, for example, 0.5 mm to 2.5 mm, such as, for example, 0.75 mm to 2.25 mm, such as, for example, 1 mm to 2 mm, and 1.25 mm to 1.75 mm, such as, for example, 1.5 mm.

[0082] The flow cytometer of the present disclosure includes a light source configured to illuminate particles in the flow stream at an inspection point in the flow cell. The number of light sources in the flow cytometer can vary. In some embodiments, the flow cytometer includes a single light source. Alternatively, the flow cytometer can include multiple light sources in some cases. In some such cases, the number of light sources ranges from 2 to 10, including, for example, 2 to 5 and 2 to 4. Any convenient light source can be used as the light source described herein. In some embodiments, the light source is a laser. In embodiments, the laser can be any convenient laser, such as a continuous wave laser. For example, the laser can be a diode laser, such as an ultraviolet diode laser, a visible diode laser, and a near infrared diode laser. In other embodiments, the laser can be a helium neon (HeNe) laser. In some cases, the laser is a gas laser, such as a helium-neon laser, an argon laser, a krypton laser, a xenon laser, a nitrogen laser, a CO2 laser, a CO2 laser, an argon-fluorine (ArF) excimer laser, a krypton-fluorine (KrF) excimer laser, a xenon-chlorine (XeCl) excimer laser, or a xenon-fluorine (XeF) excimer laser, or combinations thereof. In other cases, the subject flow cytometer includes a dye laser, such as a stilbene laser, a coumarin laser, or a rhodamine laser. In still other examples, the laser of interest includes a metal vapor laser, such as a helium-cadmium (HeCd) laser, a helium-mercury (HeHg) laser, a helium-selenium (HeSe) laser, a helium-silver (HeAg) laser, a strontium laser, a neon-copper (NeCu) laser, a copper laser, or a gold laser, and combinations thereof. In still other instances, the subject flow cytometers include a solid-state laser, such as a ruby ​​laser, a Nd:YAG laser, a NdCrYAG laser, an Er:YAG laser, a Nd:YLF laser, a Nd:YVO4 laser, a Nd:YCa4O(BO3)3 laser, a Nd:YCOB laser, a titanium sapphire laser, a slim YAG laser, a ytterbium YAG laser, a ytterbium2O3 laser, or a cerium-doped laser, and combinations thereof.

[0083] The laser light source according to certain embodiments may also include one or more optical adjustment components. In certain embodiments, the optical adjustment components may include any device located between the light source and the flow cell that can change the spatial width of the illumination or some other characteristic of the illumination from the light source, such as, for example, the illumination direction, wavelength, beam width, beam intensity, and focus. The optical adjustment protocol may include any convenient device that adjusts one or more characteristics of the light source, including, but not limited to, lenses, mirrors, filters, optical fibers, wavelength separators, pinholes, slits, collimating protocols, and combinations thereof. In certain embodiments, the subject flow cytometer includes one or more focusing lenses. The focusing lens may be a non-magnifying lens in one example. In yet other embodiments, the subject flow cytometer includes an optical fiber.

[0084] The light source may be positioned at any suitable distance from the flow cell, such as when the light source and flow cell are separated by 0.005 mm or more, including at a distance of 0.01 mm or more, such as 0.05 mm or more, such as 0.1 mm or more, such as 0.5 mm or more, such as 1 mm or more, such as 5 mm or more, such as 10 mm or more, such as 25 mm or more, and 100 mm or more. In addition, the light source may be positioned at any suitable angle relative to the flow cell, such as at an angle of, for example, 90 degrees, at an angle in the range of 10 degrees to 90 degrees, including 15 degrees to 85 degrees, such as 20 degrees to 80 degrees, such as 25 degrees to 75 degrees, and 30 degrees to 60 degrees.

[0085] In some embodiments, the light sources of interest include a plurality of lasers configured to provide laser light for discrete illumination of the flow stream, including two or more lasers, such as three or more lasers, such as four or more lasers, such as five or more lasers, such as ten or more lasers, and including fifteen or more lasers configured to provide laser light for discrete illumination of the flow stream. Depending on the desired wavelength of light for illumination of the flow stream, each laser may have a particular wavelength that varies from 200 nm to 1500 nm, including 250 nm to 1250 nm, such as 300 nm to 1000 nm, such as 350 nm to 900 nm, and 400 nm to 800 nm. In certain embodiments, the lasers of interest may include one or more of a 405 nm laser, a 488 nm laser, a 561 nm laser, and a 635 nm laser.

[0086] In certain embodiments, the light source is an optical beam generator configured to generate two or more beams of frequency-shifted light. In some cases, the optical beam generator includes a laser and a radio frequency generator configured to apply a radio frequency drive signal to an acousto-optic device to generate two or more angularly deflected laser beams. In these embodiments, the laser can be a pulsed laser or a continuous wave laser. For example, lasers in optical beam generators of interest can be gas lasers such as helium-neon lasers, argon lasers, krypton lasers, xenon lasers, nitrogen lasers, CO2 lasers, CO2 lasers, argon fluorine (ArF) excimer lasers, krypton fluorine (KrF) excimer lasers, xenon chlorine (XeCl) excimer lasers, or xenon fluorine (XeF) excimer lasers, or combinations thereof; dye lasers such as stilbene, coumarin, or rhodamine lasers; helium-cadmium (HeCd) lasers, helium-mercury (HeHg) lasers, helium-selenium (He metal vapor lasers such as Se (Se) lasers, helium-silver (HeAg) lasers, strontium lasers, neon copper (NeCu) lasers, copper lasers or gold lasers and combinations thereof; solid state lasers such as ruby ​​lasers, Nd:YAG lasers, NdCrYAG lasers, Er:YAG lasers, Nd:YLF lasers, Nd:YVO4 lasers, Nd:YCa4O(BO3)3 lasers, Nd:YCOB lasers, titanium sapphire lasers, thulium YAG lasers, ytterbium YAG lasers, ytterbium2O3 lasers, or cerium doped lasers and combinations thereof.

[0087] The acousto-optic device can be any convenient acousto-optic protocol configured to frequency shift laser light using applied acoustic waves. In certain embodiments, the acousto-optic device is an acousto-optic deflector. The acousto-optic device in the subject system is configured to generate an angularly deflected laser beam from light from a laser and an applied high frequency drive signal. The high frequency drive signal can be applied to the acousto-optic device with any suitable high frequency drive signal source, such as a direct digital synthesizer (DDS), an arbitrary waveform generator (AWG), or an electrical pulse generator.

[0088] In an embodiment, the controller is configured to generate a desired number of angularly deflected laser beams within the output laser beam, including being configured to apply, for example, 3 or more high frequency drive signals, for example, 4 or more high frequency drive signals, for example, 5 or more high frequency drive signals, for example, 6 or more high frequency drive signals, for example, 7 or more high frequency drive signals, for example, 8 or more high frequency drive signals, for example, 9 or more high frequency drive signals, for example, 10 or more high frequency drive signals, for example, 15 or more high frequency drive signals, for example, 25 or more high frequency drive signals, for example, 50 or more high frequency drive signals, and 100 or more high frequency drive signals.

[0089] In some cases, to generate an intensity profile of the angularly deflected laser beam within the output laser beam, the controller is configured to apply a high frequency drive signal having a varying amplitude, e.g., from about 0.005 V to about 400 V, e.g., from about 0.01 V to about 300 V, e.g., from about 0.05 V to about 200 V, e.g., from about 0.1 V to about 100 V, e.g., from about 0.5 V to about 75 V, e.g., from about 1 V to about 50 V, e.g., from about 2 V to about 40 V, e.g., from about 0.001 V to about 500 V, including 3 V to about 30 V and about 5 V to about 25 V. In some embodiments, each applied high frequency drive signal has a frequency of, for example, about 0.005 MHz to about 400 MHz, for example, about 0.01 MHz to about 300 MHz, for example, about 0.05 MHz to about 200 MHz, for example, about 0.1 MHz to about 100 MHz, for example, about 0.5 MHz to about 90 MHz, for example, about 1 MHz to about 75 MHz, for example, about 2 MHz to about 70 MHz, for example, about 3 MHz to about 65 MHz, for example, about 0.001 MHz to about 500 MHz, including about 4 MHz to about 60 MHz and about 5 MHz to about 50 MHz.

[0090] In certain embodiments, the controller includes a processor having a memory operably coupled to the processor, where the memory includes instructions stored in the memory that, when executed by the processor, cause the processor to generate an output laser beam having an angularly deflected laser beam with a desired intensity profile. For example, the memory may include instructions for generating two or more, e.g., three or more, e.g., four or more, e.g., five or more, e.g., ten or more, e.g., twenty-five or more, e.g., fifty or more, angularly deflected laser beams of the same intensity, including the memory may include instructions for generating one hundred or more angularly deflected laser beams of the same intensity. In other embodiments, the memory may include instructions for generating two or more, e.g., three or more, e.g., four or more, e.g., five or more, e.g., ten or more, e.g., twenty-five or more, e.g., fifty or more, angularly deflected laser beams of different intensities, including the memory may include instructions for generating one hundred or more angularly deflected laser beams of different intensities.

[0091] In certain embodiments, the controller comprises a processor having a memory operatively coupled to the processor, whereby the memory includes instructions stored in the memory that, when executed by the processor, cause the processor to generate an output laser beam that increases in intensity from an edge of the output laser beam along a horizontal axis to its center. In these cases, the intensity of the angularly deflected laser beam at the center of the output beam can range from 0.1% to about 99% of the intensity of the angularly deflected laser beam at the edge of the output laser beam along the horizontal axis, including, for example, 0.5% to about 95%, for example, 1% to about 90%, for example, about 2% to about 85%, for example, about 3% to about 80%, for example, about 4% to about 75%, for example, about 5% to about 70%, for example, about 6% to about 65%, for example, about 7% to about 60%, for example, about 8% to about 55% and about 10% to about 50% of the intensity of the angularly deflected laser beam at the edge of the output laser beam along the horizontal axis. In other embodiments, the controller comprises a processor having a memory operatively coupled to the processor, whereby the memory includes instructions stored in the memory that, when executed by the processor, cause the processor to generate an output laser beam that increases in intensity from an edge of the output laser beam along a horizontal axis to its center. In these cases, the intensity of the angularly deflected laser beam at the edge of the output beam can range from 0.1% to about 99% of the intensity of the angularly deflected laser beam at the center of the output laser beam along the horizontal axis, including, for example, 0.5% to about 95%, for example, 1% to about 90%, for example, about 2% to about 85%, for example, about 3% to about 80%, for example, about 4% to about 75%, for example, about 5% to about 70%, for example, about 6% to about 65%, for example, about 7% to about 60%, for example, about 8% to about 55% and about 10% to about 50% of the intensity of the angularly deflected laser beam at the center of the output laser beam along the horizontal axis. In yet another embodiment, the controller comprises a processor having a memory operatively coupled to the processor, whereby the memory includes instructions stored in the memory that, when executed by the processor, cause the processor to generate an output laser beam having an intensity profile having a Gaussian distribution along a horizontal axis.In yet another embodiment, the controller includes a processor having a memory operatively coupled to the processor, whereby the memory includes instructions stored in the memory that, when executed by the processor, cause the processor to generate an output laser beam having a top-hat intensity profile along a horizontal axis.

[0092] In embodiments, the subject optical beam generator may be configured to generate angularly polarized laser beams within the spatially separated output laser beam. Depending on the applied high frequency drive signal and the desired illumination profile of the output laser beam, the angularly polarized laser beams may be separated by 0.001 μm or more, for example, 0.005 μm or more, for example, 0.01 μm or more, for example, 0.05 μm or more, for example, 0.1 μm or more, for example, 0.5 μm or more, for example, 1 μm or more, for example, 5 μm or more, for example, 10 μm or more, for example, 100 μm or more, for example, 500 μm or more, for example, 1000 μm or more, and 5000 μm or more. In some embodiments, the system is configured to generate angularly polarized laser beams within the output laser beam that overlap with adjacent angularly polarized laser beams along, for example, the horizontal axis of the output laser beam. The overlap between adjacent angularly deflected laser beams (e.g., beam spot overlap) can be, for example, an overlap of 0.005 μm or more, such as an overlap of 0.01 μm or more, such as an overlap of 0.05 μm or more, such as an overlap of 0.1 μm or more, such as an overlap of 0.5 μm or more, such as an overlap of 1 μm or more, such as an overlap of 5 μm or more, such as an overlap of 0.001 μm or more, including an overlap of 10 μm or more and an overlap of 100 μm or more.

[0093] In certain cases, the light beam generator configured to generate two or more beams of frequency-shifted light includes a laser excitation module as described in U.S. Pat. Nos. 9,423,353, 9,784,661, and 10,006,852, and U.S. Patent Publication Nos. 2017 / 0133857 and 2017 / 0350803, the disclosures of which are incorporated herein by reference.

[0094] In addition, the flow cytometer includes a detector configured to collect light emitted by the illuminated particles. The light detector is configured to detect the particle-modulated light transmitted by the fiber optic collection element and generate a signal based on a characteristic (e.g., intensity) of the light. For example, the one or more particle-modulated light detectors can include one or more side scatter light detectors for detecting side-scattered wavelengths of light (i.e., light refracted and reflected from the surface and internal structure of the particle). In some embodiments, the flow cytometer includes a single side scatter light detector. In other embodiments, the flow cytometer includes multiple side scatter light detectors, including, for example, two or more, e.g., three or more, e.g., four or more, and five or more.

[0095] Any convenient detector for detecting collected light may be used in the side scatter light detectors described herein. Detectors of interest may include, but are not limited to, optical sensors or photodetectors such as active pixel sensors (APS), avalanche photodiodes, image sensors, charge-coupled devices (CCDs), intensified charge-coupled devices (ICCDs), light-emitting diodes, photon counters, bolometers, pyroelectric detectors, photoresistors, solar cells, photodiodes, photomultiplier tubes (PMTs), phototransistors, quantum dot photoconductors, or photodiodes, as well as combinations thereof, among other detectors. In certain embodiments, the collected light is measured with a charge-coupled device (CCD), a semiconductor charge-coupled device (CCD), an active pixel sensor (APS), a complementary metal oxide semiconductor (CMOS) image sensor, or an N-type metal oxide semiconductor (NMOS) image sensor. In certain embodiments, the detector may be a 0.05 cm 2 or smaller image sensor, for example. 2 ~9cm 2 , e.g., 0.1 cm 2 ~8cm 2 , e.g., 0.5 cm 2 ~7cm 2 and 1 cm 2 ~5cm 2 Including 0.01cm 2 ~10cm 2and a photomultiplier tube such as a photomultiplier tube having an active detection surface area in each region in the range of 100 nm to 150 nm.

[0096] In embodiments, the subject flow cytometers also include a fluorescent detector configured to detect one or more fluorescent wavelengths of light, hi other embodiments, the flow cytometers include a plurality of fluorescent light detectors, including, for example, two or more, e.g., three or more, e.g., four or more, five or more, ten or more, fifteen or more, and twenty or more.

[0097] Any convenient detector for detecting collected light may be used in the fluorescence detectors described herein. Detectors of interest may include, but are not limited to, optical sensors or photodetectors such as active pixel sensors (APS), avalanche photodiodes, image sensors, charge-coupled devices (CCDs), intensified charge-coupled devices (ICCDs), light-emitting diodes, photon counters, bolometers, pyroelectric detectors, photoresistors, solar cells, photodiodes, photomultiplier tubes (PMTs), phototransistors, quantum dot photoconductors, or photodiodes, as well as combinations thereof, among other detectors. In certain embodiments, the collected light is measured with a charge-coupled device (CCD), a semiconductor charge-coupled device (CCD), an active pixel sensor (APS), a complementary metal oxide semiconductor (CMOS) image sensor, or an N-type metal oxide semiconductor (NMOS) image sensor. In certain embodiments, the detector may be, for example, a 0.05 cm 2 ~9cm 2 , e.g., 0.1 cm 2 ~8cm 2 , e.g., 0.5 cm 2 ~7cm 2 and 1 cm 2 ~5cm 2 Including 0.01cm 2 ~10cm 2 and a photomultiplier tube such as a photomultiplier tube having an active detection surface area in each region in the range of 100 nm to 150 nm.

[0098] When a subject flow cytometer includes multiple fluorescence detectors, each fluorescence detector can be the same, or the set of fluorescence detectors can be a combination of different types of detectors. For example, when a subject flow cytometer includes two fluorescence detectors, in some embodiments, the first fluorescence detector is a CCD type device and the second fluorescence detector (or imaging sensor) is a CMOS type device. In other embodiments, both the first and second fluorescence detectors are CCD type devices. In still other embodiments, both the first and second fluorescence detectors are CMOS type devices. In still other embodiments, the first fluorescence detector is a CCD type device and the second fluorescence detector is a photomultiplier tube (PMT). In still other embodiments, the first fluorescence detector is a CMOS type device and the second fluorescence detector is a photomultiplier tube. In still other embodiments, both the first and second fluorescence detectors are photomultiplier tubes.

[0099] In embodiments of the present disclosure, the subject fluorescence detectors are configured to measure collected light at one or more wavelengths, including, for example, measuring light emitted by a sample in a flow stream at two or more wavelengths, e.g., five or more different wavelengths, e.g., ten or more different wavelengths, e.g., twenty-five or more different wavelengths, e.g., fifty or more different wavelengths, e.g., one hundred or more different wavelengths, e.g., two hundred or more different wavelengths, e.g., three hundred or more different wavelengths, and four hundred or more different wavelengths. In some embodiments, two or more detectors in a module described herein are configured to measure the same or overlapping wavelengths of collected light.

[0100] In some embodiments, the subject fluorescence detectors are configured to measure light collected over a range of wavelengths (e.g., 200 nm to 1000 nm). In certain embodiments, the subject detectors are configured to collect a spectrum of light over a range of wavelengths. For example, a flow cytometer may include one or more detectors configured to collect a spectrum of light over one or more of the wavelength ranges of 200 nm to 1000 nm. In still other embodiments, the subject detectors are configured to measure light emitted by a sample in a flow stream at one or more specific wavelengths. For example, a module may include one or more detectors configured to measure light at one or more of 450 nm, 518 nm, 519 nm, 561 nm, 578 nm, 605 nm, 607 nm, 625 nm, 650 nm, 660 nm, 667 nm, 670 nm, 668 nm, 695 nm, 710 nm, 723 nm, 780 nm, 785 nm, 647 nm, 617 nm, and any combination thereof. In certain embodiments, one or more detectors may be configured to be paired with a particular fluorophore, such as one that is used with a sample in a fluorescence assay.

[0101] The flow cytometer may include any suitable mechanism for providing sheath and sample fluids to the sample fluid input coupler and the sheath fluid input coupler. For example, the sample fluid input coupler may be fluidly connected to a sample fluid line (e.g., tubing) that is fluidly connected to a sample fluid reservoir. Similarly, the sheath fluid input coupler may be fluidly connected to a sheath fluid line that is fluidly connected to a sheath fluid reservoir. Similarly, the flow cytometer may include any suitable mechanism for managing waste from the flow stream. The fluid output coupler may be fluidly connected to a waste line that is fluidly connected to a waste reservoir. A fluid management system that may be adapted for use in the subject flow cytometer is provided in U.S. Patent Application Publication No. 2022 / 0341838, the disclosure of which is incorporated herein by reference in its entirety.

[0102] Suitable flow cytometry systems include, but are not limited to, those described in Ormerod (ed.), Flow Cytometry: A Practical Approach, Oxford Univ. Press (1997); Jaroszeski et al. (eds.), Flow Cytometry Protocols, Methods in Molecular Biology No. 91, Humana Press (1997); Practical Flow Cytometry, 3rd ed., Wiley-Liss (1995); Virgo, et al. (2012) Ann Clin Biochem. Jan; 49(pt 1): 17-28; Linden, et. al., Semin Thromb Hemost. 2004 Oct; 30(5): 502-11; Alison, et al. J Pathol, 2010 Dec; 222(4): 335-344; and Herbig, et al. (2007) Crit Rev Ther Drug Carrier Syst. 24(3):203-255, the disclosures of which are incorporated herein by reference.In certain instances, flow cytometry systems of interest include BD Biosciences FACSCanto™ flow cytometers, BD Biosciences FACSCanto™ II flow cytometers, BD Accuri™ flow cytometers, BD Accuri™ C6 Plus flow cytometers, BD Biosciences FACSCelesta™ flow cytometers, BD Biosciences FACSLyric™ flow cytometers, BD Biosciences FACSVerse™ flow cytometers, BD Biosciences FACSymphony™ flow cytometers, BD Biosciences LSRFortessa™ flow cytometers, BD Biosciences LSRFortessa™ X-20 flow cytometers, BD Biosciences FACSPresto™ flow cytometers, BD Biosciences FACSVia™ flow cytometers, as well as BD Biosciences FACSCalibur™ cell sorters, BD Biosciences FACSCount™ cell sorters, BD Biosciences FACSLyric™ cell sorters, and ... These include BD Biosciences Via™ cell sorters, BD Biosciences Influx™ cell sorters, BD Biosciences Jazz™ cell sorters, BD Biosciences Aria™ cell sorters, BD Biosciences FACSAria™ II cell sorters, BD Biosciences FACSAria™ III cell sorters, BD Biosciences FACSAria™ Fusion cell sorters, and BD Biosciences FACSMelody™ cell sorters, BD Biosciences FACSymphony™ S6 cell sorters, BD Biosciences FACSDiscover™ cell sorters, and others.

[0103] In some embodiments, the subject systems are disclosed in U.S. Pat. Nos. 10,663,476, 10,620,111, 10,613,017, 10,605,713, 10,585,031, 10,578,542, 10,578,469, 10,481,074, 10,302,545, 10,585,031, 10,578,542, 10,578,469, 10,481,074, 10,302,545, 10,585,031, 10,578,542, 10,578,469, 10,481,074, 10,302,545, 10,585,031, 10,578,542, 10,578,469, 10,481,074, 10,585,031 ...85,031, 10,585,031, 10,585,031, 10,585,031, 10,585,031, 10,585,031, No. 10,145,793, No. 10,113,967, No. 10,006,852, No. 9,952,076, No. 9,933,341, No. 9, No. 726,527, No. 9,453,789, No. 9,200,334, No. 9,097,640, No. 9,095,494, No. 9,092,034, No. 8,975,595, No. 8,753,573, No. 8,233,146, No. 8,140,300, No. 7,544,326, No. 7,201,8 No. 75, No. 7,129,505, No. 6,821,740, No. 6,813,017, No. 6,809,804, No. 6,372,506, No. 5,7 Nos. 5,643,796, 5,627,040, 5,620,842, 5,602,039, 4,987,086, and 4,498,766, the disclosures of which are incorporated by reference in their entireties.

[0104] In some embodiments, the flow cytometer is configured as an imaging flow cytometer. For example, in certain cases, the subject system is a flow cytometry system configured to image particles in a flow stream by FIRE(), such as those described in Diebold, et al. Nature Photonics Vol. 7(10); 806-810 (2013), and in U.S. Patent Nos. 9,423,353, 9,784,661, and 10,006,852, and U.S. Patent Publication Nos. 2017 / 0133857 and 2017 / 0350803, the disclosures of which are incorporated herein by reference. In some embodiments where the flow cytometer is a particle sorter, the particle sorter is an image-enabled particle sorter. Image-enabled particle sorters are described in US Provisional Patent Applications Nos. 63 / 431,803 and 63 / 465,057, the disclosures of which are incorporated herein by reference in their entireties.

[0105] FIG. 2 shows a system 200 for flow cytometry according to an illustrative embodiment of the present disclosure. The system 200 includes a laser 201 configured to irradiate particles 211 in a flow stream 214 at an inspection point 215 in a flow cell 210. The example of FIG. 2 shows a single laser, but it is understood that multiple lasers may also be used. The laser beam from the laser 201 is then directed to a focusing lens 202, which focuses the beam in the flow cell 210 onto a portion of the fluid stream where the particles 211 of the sample are located. The flow cell 210 is part of a fluidics system that directs particles in the stream, typically one at a time, into the focused laser beam for inspection. Alternatively, if the flow cytometer is a stream-in-air cytometer, a nozzle top may be used.

[0106] As shown in FIG. 2, the flow cell 210 is fluidly connected to a sheath fluid reservoir 203 comprising a sheath fluid and a sample fluid reservoir 204 comprising a sample fluid. The sheath fluid from the sheath fluid reservoir 203 is provided to at least one sheath fluid injection port 208 via a conduit (i.e., a sheath fluid line) 207. In addition, a sample fluid containing particles 211 from the sample fluid reservoir 204 is provided to a sample injection port 206 via a conduit (i.e., a sample fluid line) 205. The sample injection port 206 is fluidly connected to a sample injector 213 (e.g., a sample injection needle) configured to introduce the particles 211 into the interior of the flow cell 210. The particles 211 are hydrodynamically focused via the sheath fluid entering from the sheath fluid injection port 208 such that a flow stream 214 is formed downstream of the tapered portion 212 of the flow cell 210. Particles released at the distal end of flow cell 210 may be disposed of and / or collected via any suitable protocol. For example, depending on the type of flow cytometry being performed, particles may be collected at the distal end of flow cell 210, for example, via a waste line. Alternatively, particles may be sorted.

[0107] The light from the laser beam interacts with the particles 211 in the sample by diffraction, refraction, reflection, scattering, and absorption with re-emission at a variety of different wavelengths depending on the particle's properties such as the particle's size, internal structure, and the presence of one or more fluorescent molecules attached or naturally present on or in the particle. The fluorescent emission, as well as the diffracted, refracted, reflected, and scattered light, may be routed to one or more detectors. In particular, the forward scattered light (FSC) is routed to the forward scattered light detector 223. The forward scattered light detector 223 is positioned slightly off-axis from the direct beam through the flow cell and configured to detect the diffracted light, the excitation light traveling mostly in a forward direction through or around the particle. The intensity of the light detected by the forward scattered light detector 223 depends on the overall size of the particle. The forward scattered light detector may include, for example, a photodiode. Disposed between the forward scattered light detector 223 are an optical filter 221a and a scattering bar 222. The optical filter 221a may be configured to filter out at least one wavelength of non-FSC light, while the scattering bar 222 may be configured to prevent the incident beam from the laser 201 (i.e., non-scattered light) from being detected by the forward scattered light detector 223.

[0108] In addition, side-scattered light (SSC) is detected by the side-scattered light detector 224. In other words, the side-scattered light detector 224 is configured to detect diffracted and reflected light from the surface and internal structure of the particle 211, which tends to increase as the particle structure becomes more complex. In the example of FIG. 2, the flow cytometer 200 includes a dichroic mirror 220a configured to reflect SSC light to the side-scattered light detector 224 while passing non-SSC (e.g., fluorescent) light. The optical filter 221b is configured to prevent at least one wavelength of non-SSC light from being detected by the side-scattered light detector 224. Also shown are fluorescent light detectors 225a-225c, each configured to detect fluorescent light of a different wavelength. For example, the dichroic mirror 220b can be configured to reflect fluorescent light (FL) corresponding to a first wavelength (or range of wavelengths) to the fluorescent light detector 225a while passing light of other wavelengths. The optical filter 221c may be configured to prevent at least one wavelength of light that does not correspond to the first wavelength (or range of wavelengths) from being detected by the fluorescence detector 225a. Similarly, the dichroic mirror 220c is configured to reflect the FL light corresponding to the second wavelength (or range of wavelengths) to the fluorescence detector 225b while passing the light of the third wavelength (or range of wavelengths) for detection by the fluorescence detector 225c. The optical filter 221d is configured to prevent at least one wavelength of light that does not correspond to the second wavelength (or range of wavelengths) from being detected by the fluorescence detector 225b. In addition, the optical filter 221e is configured to prevent at least one wavelength of light that does not correspond to the third wavelength (or range of wavelengths) from being detected by the fluorescence detector 225c.

[0109] Those skilled in the art will recognize that a flow cytometer according to an embodiment of the present disclosure is not limited to the flow cytometer depicted in Figure 2, but may include any flow cytometer known in the art. For example, a flow cytometer may have any number of lasers, beam splitters, filters, and detectors at various wavelengths and in a variety of different configurations. For example, the embodiment of Figure 2 shows three fluorescent detectors for illustrative purposes, but it will be understood that any suitable number of fluorescent detectors may be used.

[0110] During operation, the operation of the flow cytometer is controlled by the controller / processor 290, and measurement data from the detectors may be stored in memory 295 and processed by the controller / processor 290. Although not explicitly shown, the controller / processor 290 may be coupled to the detectors to receive output signals therefrom, and may also be coupled to electrical and electromechanical components of the flow cytometer to control the laser 201, fluid flow parameters, and the like. Input / output (I / O) functionality 297 may also be provided within the system. The memory 295, controller / processor 290, and I / O 297 may be provided as an integral part of the flow cytometer as a whole. In such an embodiment, a display may also form part of the I / O functionality 297 for presenting experimental data to a user of the flow cytometer 200. Alternatively, the memory 295 and the controller / processor 290 and some or all of the I / O functionality may be part of one or more external devices, such as a general purpose computer. In some embodiments, memory 295 and some or all of controller / processor 290 may be in wireless or wired communication with flow cytometer 210. In conjunction with memory 295 and I / O 297, controller / processor 290 may be configured to perform a variety of functions associated with the preparation and analysis of flow cytometer experiments.

[0111] The various fluorescent molecules in the fluorochrome panel used in a flow cytometer experiment will emit light in their own characteristic wavelength bands. The particular fluorescent labels used in the experiment and their associated fluorescent emission bands can be selected to generally match the filter window of the detector. The I / O 297 can be configured to receive data relating to a flow cytometer experiment having a panel of fluorescent labels and a plurality of cell populations having a plurality of markers, each cell population having a subset of the plurality of markers. The I / O 297 can also be configured to receive biological data assigning one or more markers to one or more cell populations, marker concentration data, emission spectrum data, data assigning labels to one or more markers, and cytometer configuration data. Flow cytometer experiment data, such as label spectral characteristics and flow cytometer configuration data, can also be stored in memory 295. The controller / processor 290 can be configured to evaluate one or more assignments of labels to markers.

[0112] In some embodiments, the subject system is a particle sorting system configured to sort particles using an enclosed particle sorting module, such as that described in U.S. Patent Publication No. 2017 / 0299493, filed March 28, 2017, the disclosure of which is incorporated herein by reference. In certain embodiments, particles (e.g., cells) of a sample are sorted using a sort determination module having multiple sort determination units, such as that described in U.S. Patent Publication No. 2020 / 0256781, filed December 23, 2019, the disclosure of which is incorporated herein by reference. In some embodiments, a system for sorting components of a sample includes a particle sorting module having a deflection plate, such as that described in U.S. Patent Publication No. 2017 / 0299493, filed March 28, 2017, the disclosure of which is incorporated herein by reference.

[0113] In one particular embodiment, the system is a fluorescence imaging using radio frequency tagged luminescence image enabled particle sorter as depicted in FIG. 3. The particle sorter 300 includes an optical illumination component 300a including a light source 301 (e.g., a 488 nm laser) generating an output beam of light 301a that is split into beams 302a and 302b by a beam splitter 302. The light beam 302a is propagated through an acousto-optic device (e.g., an acousto-optic deflector, AOD) 303 to generate an output beam 303a having one or more angularly deflected light beams. In some cases, the output beam 303a generated from the acousto-optic device 303 includes a local oscillator beam and multiple radio frequency comb beams. The light beam 302b is propagated through an acousto-optic device (e.g., an acousto-optic deflector, AOD) 304 to generate an output beam 304a having one or more angularly deflected light beams. In some cases, the output beam 304a generated from the acousto-optic device 304 includes a local oscillator beam and multiple high frequency comb beams. The output beams 303a and 304a generated from the acousto-optic devices 303 and 304, respectively, are combined with a beam splitter 305 to generate an output beam 305a that is transmitted through an optical component 306 (e.g., an objective lens) for irradiating particles in a flow cell 307. In one particular embodiment, the acousto-optic device 303 (AOD) splits a single laser beam into an array of beamlets, each having a different optical frequency and angle. A second AOD 304 tunes the optical frequency of a reference beam, which is then overlapped with the array of beamlets at the beam combiner 305. In certain embodiments, the light irradiation system having a light source and an acousto-optical device also includes those described in Schraivogel, et al. ("High-speed fluorescence image-enabled cell sorting" Science (2022), 375(6578):315-320) and U.S. Patent Publication No. 2021 / 0404943, the disclosures of which are incorporated herein by reference.

[0114] Output beam 305a illuminates a sample particle 308 propagating through a flow cell 307 (e.g., with sheath fluid 309) in an illumination region 310. As shown in illumination region 310, multiple beams (e.g., angularly deflected high frequency shifted light beams depicted as dots across illumination region 310) overlap with a reference local oscillator beam (depicted as a shaded line across illumination region 310). Due to their different optical frequencies, the overlapping beams exhibit a beating behavior, whereby each beamlet emits a different frequency f 1-n delivers sinusoidal modulation.

[0115] Light from the illuminated sample is transmitted to a light detection system 300b that includes multiple photodetectors. Light detection system 300b includes a forward scattered light photodetector 311 for generating a forward scattered light image 311a, and a side scattered light photodetector 312 for generating a side scattered light image 312a. Light detection system 300b also includes a brightfield photodetector 313 for generating a light loss image 313a. In some embodiments, forward scatter detector 311 and side scatter detector 312 are photodiodes (e.g., avalanche photodiodes, APDs). In some cases, brightfield photodetector 313 is a photomultiplier tube (PMT). Fluorescence from the illuminated sample is also detected by fluorescence photodetectors 314-317. In some cases, photodetectors 314-317 are photomultiplier tubes. Light from the illuminated sample is directed through beam splitter 320 to side scatter detection channel 312 and fluorescence detection channels 314-317. Light detection system 300b includes bandpass optics 321, 322, 323, and 324 (e.g., dichroic mirrors) for transmitting light of predetermined wavelengths to photodetectors 314-317. In some cases, optic 321 is 534 nm / 40 nm bandpass. In some cases, optic 322 is 586 nm / 42 nm bandpass. In some cases, optic 323 is 700 nm / 54 nm bandpass. In some cases, optic 324 is 783 nm / 56 nm bandpass. The first number represents the center of the spectral band. The second number provides the range of the spectral band. Thus, a 510 / 20 filter spans 10 nm on each side of the center of the spectral band, or from 500 nm to 520 nm.

[0116] Data signals generated in response to light detected in the scattered light detection channels 311 and 312, the brightfield light detection channel 313, and the fluorescence detection channels 314-317 are processed by real-time digital processing by processors 350 and 351. Images 311a-317a can be generated in each light detection channel based on the data signals generated by the processors 350 and 351. Image-enabled sorting is performed in response to a sort signal generated by a sort trigger 352. The sorting component 300c includes a deflection plate 331 for deflecting particles into a sample container 332 or into a waste stream 333. In some cases, the sorting component 300c is configured to sort particles using an enclosed particle sorting module, such as that described in U.S. Patent Publication No. 2017 / 0299493, filed March 28, 2017, the disclosure of which is incorporated herein by reference. In one particular embodiment, the sorting component 300c sorts using a sorting decision module having multiple sorting decision units, such as that described in U.S. Patent Publication No. 2020 / 0256781, the disclosure of which is incorporated herein by reference.

[0117] In some embodiments, the system is a particle analyzer that can analyze and characterize particles with or without physically sorting the particles into a collection vessel using a particle analysis system 401 (FIG. 4). FIG. 4 shows a functional block diagram of a particle analysis system for computation-based sample analysis and particle characterization. In some embodiments, the particle analysis system 401 is a flow system. The particle analysis system 401 includes a fluidics system 402. The fluidics system 402 can include or be coupled to a sample tube 405 and a moving fluid column within the sample tube through which the particles 403 (e.g., cells) of the sample move along a common sample path 409.

[0118] The particle analysis system 401 includes a detection system 404 configured to collect a signal from each particle as it passes through one or more detection stations along a common sample path. The detection station 408 generally refers to a monitoring area 407 of the common sample path. In some implementations, detection may include detecting light, or one or more other characteristics, of the particles 403 as they pass through the monitoring area 407. In FIG. 4, one detection station 408 is shown with one monitoring area 407. Some implementations of the particle analysis system 401 may include multiple detection stations. Additionally, some detection stations may monitor more than one area.

[0119] Each signal is assigned a signal value to form a data point for each particle. As described above, this data may be referred to as event data. The data points may be multi-dimensional data points that include values ​​of respective properties measured for the particle. The detection system 404 is configured to collect a series of such data points at a first time interval.

[0120] The particle analysis system 401 may also include a control system 406. The control system 406 may include one or more processors, amplitude control circuitry, and / or frequency control circuitry. The illustrated control system may be operatively associated with the fluidics system 402. The control system may be configured to generate a calculated signal frequency for at least a portion of a first time period based on the Poisson distribution and the number of data points collected by the detection system 404 during the first time period. The control system 406 may further be configured to generate an empirical signal frequency based on the number of data points in the portion of the first time period. The control system 406 may additionally compare the empirical signal frequency to that of the calculated signal frequency or a predetermined signal frequency.

[0121] 5 shows a functional block diagram of one embodiment of a particle analyzer control system for analyzing and displaying biological events, such as an analysis controller (i.e., processor) 500. The analysis controller 500 can be configured to implement various processes for controlling the graphical display of biological events.

[0122] The particle analyzer or sorting system 502 may be configured to acquire biological event data. For example, a flow cytometer may generate flow cytometric event data. The particle analyzer 502 may be configured to provide the biological event data to the analysis controller 500. A data communication channel may be included between the particle analyzer or sorting system 502 and the analysis controller 500. The biological event data may be provided to the analysis controller 500 via the data communication channel. The analysis controller 500 may be a processor configured to perform the method of the present invention by, for example, applying a regression model to determine a relationship between an initial set of analyte features and a cluster criterion, generating a sparse set from at most a portion of the initial set of analyte features based on the relationship, generating a classification model based on the sparse set, and applying the classification model to classify the analyte data into clusters.

[0123] The analysis controller 500 can be configured to receive biological event data from a particle analyzer or sorting system 502. The biological event data received from the particle analyzer or sorting system 502 can include flow cytometric event data. The analysis controller 500 can be configured to provide a graphical display including a first plot of the biological event data on a display device 506. The analysis controller 500 can be further configured to render a region of interest as a gate around a population of biological event data shown by the display device 506, e.g., overlaid on the first plot. In some embodiments, the gate can be a logical combination of one or more graphical regions of interest depicted on a single parameter histogram or bivariate plot. In some embodiments, the display can be used to display particle parameters or saturated detector data.

[0124] Analysis controller 500 can further be configured to display the biological event data within the gate on display device 506 differently than other events within the biological event data outside the gate. For example, analysis controller 500 can be configured to render the color of the biological event data contained within the gate to be distinct from the color of the biological event data outside the gate. Display device 506 can be implemented as a monitor, tablet computer, smartphone, or other electronic device configured to present a graphical interface.

[0125] The analysis controller 500 can be configured to receive a gate selection signal identifying a gate from a first input device. For example, the first input device can be implemented as a mouse 510. The mouse 510 can initiate a gate selection signal (e.g., by clicking on a desired gate when positioning a cursor thereon) to the analysis controller 500 that identifies the gate to be displayed or manipulated via the display device 506. In some implementations, the first device can be implemented as a keyboard 508 or other means for providing an input signal to the analysis controller 500, such as a touch screen, an input pen, a photodetector, or a voice recognition system. Some input devices can include multiple input functions. In such implementations, each input function can be considered an input device. For example, as shown in FIG. 5, the mouse 510 can include a right mouse button and a left mouse button, each of which can generate an activation event.

[0126] This triggering event can cause the analysis controller 500 to change the way the data is displayed, what portions of the data are actually displayed on the display device 506, and / or provide input for further processing, such as selecting a population for particle sorting.

[0127] In some embodiments, the analysis controller 500 can be configured to detect when a gate selection is initiated by the mouse 510. The analysis controller 500 can be further configured to automatically modify the visualization of the plot to facilitate the gating process. This modification can be based on a particular distribution of the biological event data received by the analysis controller 500.

[0128] The analysis controller 500 may be connected to a storage device 504. The storage device 504 may be configured to receive and store the biological event data from the analysis controller 500. The storage device 504 may also be configured to receive and store flow cytometric event data from the analysis controller 500. The storage device 504 may be further configured to enable retrieval of the biological event data, such as the flow cytometric event data, by the analysis controller 500.

[0129] The display device 506 can be configured to receive display data from the analysis controller 500. The display data can include a plot of the biological event data and a gate that delineates a section of the plot. The display device 506 can be further configured to modify the presented information according to input received from the analysis controller 500 in conjunction with input from the particle analyzer 502, the storage device 504, the keyboard 508, and / or the mouse 510.

[0130] In some implementations, the analysis controller 500 can generate a user interface to receive the exemplary events for sorting. For example, the user interface can include a control for receiving the exemplary events or exemplary images. The exemplary events or images, or the exemplary gates, can be provided prior to collection of event data for the sample or based on an initial set of events for a portion of the sample.

[0131] FIG. 6A is a schematic diagram of a particle sorter system 600 (e.g., particle analyzer or sorting system 502) according to one embodiment presented herein. In some embodiments, the particle sorter system 600 is a cell sorter system. As shown in FIG. 6A, a droplet forming transducer 602 (e.g., a piezoelectric oscillator) is coupled to a fluid conduit 601, which can be coupled to, can include, or can be a nozzle 603. Within the fluid conduit 601, a sheath fluid 604 hydrodynamically focuses a sample fluid 606 containing particles 609 into a moving fluid column 608 (e.g., a stream). Within the moving fluid column 608, the particles 609 (e.g., cells) are aligned in single file across an area to be monitored 611 (e.g., where laser streams intersect) and are illuminated by an illumination source 612 (e.g., a laser). Vibration of the droplet forming transducer 602 causes the moving fluid column 608 to break up into multiple droplets 610 , some of which contain particles 609 .

[0132] In operation, the detection station 614 (e.g., an event detector) identifies when a particle of interest (or cell of interest) crosses the monitored area 611. The detection station 614 feeds into a timing circuit 628, which in turn feeds into a flash charge circuit 630. At a droplet break-off point, signaled by a timed droplet delay (Δt), a flash charge can be applied to the moving fluid column 608 such that the droplets of interest carry a charge. The droplets of interest may contain one or more particles or cells to be sorted. The charged droplets can then be sorted by activating a deflection plate (not shown) to deflect the droplets into a container such as a collection tube or a multi-well or microwell sample plate where a well or microwell can be associated with a particular droplet of interest. As shown in FIG. 6A, the droplets can be collected in a drain container 638.

[0133] The detection system 616 (e.g., a droplet boundary detector) serves to automatically determine the phase of the droplet drive signal as a particle of interest passes through the monitored area 611. An exemplary droplet boundary detector is described in U.S. Pat. No. 7,679,039, which is incorporated by reference herein in its entirety. The detection system 616 allows the instrument to accurately calculate the position of each detected particle in the droplet. The detection system 616 may input an amplitude signal 620 and / or a phase 618 signal, which then inputs (via amplifier 622) to an amplitude control circuit 626 and / or a frequency control circuit 624. The amplitude control circuit 626 and / or the frequency control circuit 624 then control the droplet forming transducer 602. The amplitude control circuit 626 and / or the frequency control circuit 624 may be included within a control system.

[0134] In some implementations, the sort electronics (e.g., detection system 616, detection station 614, and processor 640) may be coupled with a memory configured to store the detected events and the sort decision based thereon. The sort decision may be included in the particle event data. In some implementations, the detection system 616 and detection station 614 may be implemented as a single detection unit or may be communicatively coupled such that event measurements may be collected by one of the detection system 616 or detection station 614 and provided to a non-collection element.

[0135] FIG. 6B is a schematic diagram of a particle sorter system according to one embodiment presented herein. The particle sorter system 600 shown in FIG. 6B includes deflection plates 652 and 654. An electric charge can be applied via a stream charging wire in the barb. This creates a stream of droplets 610 containing the particles 610 for analysis. The particles can be illuminated with one or more light sources (e.g., lasers) to generate light scattering and fluorescence information. Information about the particles is analyzed, such as by sorting electronics or other detection systems (not shown in FIG. 6B). The deflection plates 652 and 654 can be independently controlled to attract or repel the charged droplets and direct them toward a desired collection vessel (e.g., one of 672, 674, 676, or 678). As shown in FIG. 6B, the deflection plates 652 and 654 can be controlled to direct the particles along a first path 662 toward vessel 674 or along a second path 668 toward vessel 678. If the particle is not of interest (e.g., does not exhibit scattering or illumination information within a specified sorting range), the deflector may allow the particle to continue along flow path 664. Such uncharged droplets may be diverted into a waste container, such as via aspirator 670.

[0136] Sorting electronics may be included to initiate the collection of measurements, receive fluorescent signals about the particles, and determine how to adjust the deflection plates to cause particle sorting. Exemplary implementations of the embodiment shown in Figure 6B include the BD FACSAria™ line of flow cytometers, commercially available from Becton, Dickinson and Company (Franklin Lakes, NJ).

[0137] FIG. 7 depicts a general architecture of an exemplary computing device 700 according to a particular embodiment. The general architecture of the computing device 700 depicted in FIG. 7 includes an arrangement of computer hardware and software components. However, not all of these generally conventional elements need to be shown in order to provide a valid disclosure. As illustrated, the computing device 700 includes a processing unit 710, a network interface 720, a computer-readable medium drive 730, an input / output device interface 740, a display 750, and an input device 760, all of which can communicate with each other via a communication bus. The network interface 720 can provide a connection to one or more networks or computing systems. Thus, the processing unit 710 can receive information and instructions from other computing systems or services via a network. The processing unit 710 can also communicate with a memory 770 and can further provide output information for an optional display 750 via the input / output device interface 740. For example, analysis software stored as executable instructions in non-transitory memory of the analysis system (e.g., data analysis software or programs such as FlowJo®) can display flow cytometry event data to a user. The input / output device interface 740 can also receive input from optional input devices 760, such as a keyboard, mouse, digital pen, microphone, touch screen, gesture recognition system, voice recognition system, game pad, accelerometer, gyroscope, or other input device.

[0138] Memory 770 may include computer program instructions (in some embodiments grouped as modules or components) that processing unit 710 executes in sequence to perform one or more embodiments. Memory 770 typically includes RAM, ROM, and / or other persistent, secondary, or non-transitory computer readable media. Memory 770 may store an operating system 772 that provides computer program instructions for use by processing unit 710 in the general management and operation of computing device 700. Data may be stored in data storage device 790. Memory 770 may further include computer program instructions and other information for implementing aspects of the present disclosure.

[0139] kit Aspects of the present disclosure further include kits, which include storage media such as magneto-optical disks, CD-ROMs, CD-Rs, magnetic tapes, non-volatile memory cards, ROMs, DVD-ROMs, Blu-ray disks, solid state disks, and network attached storage devices (NAS). Any of these program storage media, or others now in use or that may later be developed, may be included in the subject kits. In embodiments, the program storage media includes instructions for classifying flow cytometer data. In embodiments, the instructions included in the computer readable media provided in the subject kits, or portions thereof, may be implemented as software components of software for analyzing data. In these embodiments, a computer control system according to the present disclosure may function as a software "plug-in" to an existing software package (e.g., FlowJo®).

[0140] In addition to the above components, the subject kits may further include (in some embodiments) instructions. These instructions may be present in the subject kits in a variety of forms, one or more of which may be present in the kit. One form in which these instructions may be present is as printed information on a suitable medium or substrate, such as on a piece of paper on which the information is printed, in the kit packaging, in a package insert, etc. Yet another form in which these instructions may be present is as a computer readable medium on which the information is recorded, such as a diskette, a compact disc (CD), a portable flash drive, etc. Yet another form in which these instructions may be present is as a website address that may be used via the Internet to access the information at a remote site.

[0141] Utilities The subject particle analyzers, methods, and computer systems find use in a variety of applications where it is desirable to analyze and, optionally, sort particle components within a sample in a fluid medium, such as a biological sample, and then store the sorted product for later use, such as, for example, therapeutic use. The present disclosure finds use particularly where it is desirable to sort flow cytometer data. For example, the subject particle analyzers, methods, and computer systems may be used to facilitate the determination of a suitable gate for a particular population or subpopulation of flow cytometer data, particularly in data sets where such a suitable gate is not readily apparent. Embodiments of the present disclosure are also used where it is desirable to provide a flow cytometer with improved cell sorting accuracy, improved particle collection, particle charging efficiency, more accurate particle charging, and improved particle deflection during cell sorting.

[0142] Embodiments of the present disclosure find use in applications where cells prepared from a biological sample may be desirable for research, laboratory testing, or therapeutic use. In some embodiments, the subject methods and devices may facilitate obtaining and / or analyzing individual cells prepared from a target fluid or tissue biological sample. For example, the subject methods and systems may facilitate obtaining cells from a fluid or tissue sample used as a research or diagnostic specimen for a disease such as cancer. Similarly, the subject methods and systems may facilitate obtaining cells from a fluid or tissue sample used in therapy.

[0143] The following are offered by way of example and not by way of limitation.

[0144] experiment Experiment 1 The inclusion of cell doublets in targeted single cell sorting has obvious consequences in that non-target cells can contaminate the sort product and lead to misleading or undesired results in downstream applications. Doublets consisting of cells and undegraded red blood cells, large exosomes, apoptotic bodies or platelets can also affect the outcome of the sort. The inclusion and / or exclusion of these events in the sort and their possible impact on the quality of the sort product were investigated.

[0145] In summary, blood mononuclear cells (PBMCs) were prepared by Ficoll separation from five healthy donors. Sample preparations were counterstained with DRAQ5, a membrane-permeant DNA intercalating dye compatible with BD CellView™ Image Technology. Singlet, doublet and clump frequencies were tracked via DNA content as traditional scatter-based doublet discrimination strategies were compared to image-based approaches. Each gate along the workflow was compared using DNA content as ground truth for singlet versus non-singlet events. Traditional scatter-based approaches such as width vs. height and area vs. height were performed in conjunction with an image-based approach using eccentricity and radial moment features. Image-based approaches were evaluated alone and in conjunction with scatter-based methods. Singlet preservation was also evaluated as significant loss of singlets was an undesirable consequence of a successful doublet exclusion strategy.

[0146] Sample preparation and data acquisition Whole blood was collected in standard EDTA sample collection tubes. Peripheral blood mononuclear cells (PBMCs) were prepared using a standard ficol density gradient centrifugation protocol. Blood from five healthy donors was processed in parallel. PBMCs were washed and stained with Draq5 (BD Biosciences catalog number 564902). Cells were acquired on a BD FACSDiscover™ S8 using a CellView™ Image Technology prototype. Data was analyzed with FlowJo™ software (BD Biosciences).

[0147] Manual Gating Techniques Doublet decision gating based on scatter (SSC and FSC) was performed without the use of imaging in any fashion, as we sought to capture the practice used by users on non-imaging capable cytometers. The use of imaging was not limited to features derived from numerical images, and pop-up mouse-over imaging was used to guide gate placement.

[0148] Machine Learning (ML) Algorithm Techniques A training dataset with 25K events was used to find regression relationships between predictors and targets (DRAQ5 DNA staining indicator). A top 10 feature list was generated and then iteratively fine-tuned to arrive at a sparse 3-feature set (Figure 8A). The underlying distribution was assumed to be a multimodal Gaussian mixture and unsupervised clustering was performed on 375K events (10 datasets) (Figure 8B).

[0149] result The imaging features used in the manual gating method were eccentricity and radial moment. Eccentricity is the ratio of the shortest axis moment to the longest axis moment in an image in a given scattering or fluorescence channel, while radial moment is the average distance of all signal positive pixels from the centroid (relative center) in an image in a given scattering or fluorescence channel. In Figure 9, the distribution of lymphocytes, monocytes and high scattering events is shown in the scatter plot and imaging feature plot. Next, the non-singlet exclusion method based on image features and scatter was compared. As shown in Figure 10A, the use of DRAQ5 (DNA stain) allowed the enumeration of the absolute number of singlets and non-singlets in each gate. The number of ground truth singlets and non-singlets (based on DNA content) within and outside each gate are shown as pie charts. As shown in Figure 10B, 83% of non-singlets were excluded and 95% of all singlets were preserved using the non-singlet exclusion method using imaging only. Results from a non-singlet exclusion method using height vs. width in addition to imaging are shown in Figures 11A-11B. Such a workflow combines scattering and image-based approaches to doublet identification. In the right-most plot of Figure 11A, a more aggressive gate configured to exclude more non-singlets is also shown. Metrics from this gate are shown in the bottom plot of Figure 11B, while results from the other gate are shown in the top plot of Figure 11B. Results from a non-singlet exclusion method using height vs. area in addition to imaging are shown in Figures 12A-12B. This workflow also combines scattering and image-based approaches to doublet identification. As shown in Figure 12B, 91% of the non-singlets were excluded while 92% of all singlets were preserved. Bar graphs of the percentage of all non-singlets excluded by each method are shown in Figure 13A (n=5 donors). Bar graphs of the percentage of singlets preserved by each are shown in Figure 13B. Data for each donor were normalized to the absolute number of non-singlets / singlets as measured by DNA content.

[0150] The clustering results of the machine learning based algorithmic method were plotted. Figure 14A shows the clustering results of GT singlets (magenta), GT non-singlets (blue), algorithmically identified non-singlets (which are true singlets) (orange), and algorithmically identified singlets (which are true non-singlets) (light blue). Figure 14B shows all algorithmically identified singlets (violet) and algorithmically identified non-singlets (light blue). The box plots depicted in Figure 15 show that the median true singlet identification rate is about 97% (blue) and the true doublet exclusion rate is about 92% (orange). The SD of the singlet distribution is 0.52 and the SD of the doublet distribution is 1.72.

[0151] conclusion Doublet discrimination based on scattering excluded approximately 60% of doublets (H vs. W and H vs. A were roughly equivalent) and preserved approximately 95% of singlets. Doublet discrimination based on imaging features alone excluded 80% of doublets and preserved 95% of singlets. Combining imaging and scattering parameters excluded 90% of doublets and preserved 90% of singlets. Aggressive imaging gates were able to exclude 97% of doublets but preserved only 78% of true singlets. The ML-based algorithm was able to include 97% of true singlets and exclude 92% of true non-singlets. The combination of imaging and non-imaging parameters was powerful for singlet vs. non-singlet discrimination. The underlying distribution of events closely followed the multimodal Gaussian assumption. Gaussian clustering outperformed K-means, Spectral, DBSCAN, and BIRCH clustering methods in this application.

[0152] Experiment 2 An initial feature list was generated using the DRAQ5 DNA stain indicator, the R3(700)-A channel as the target, and all other non-detector channels as predictors. The regression relationship between the predictors and targets resulted in a top 10 feature list. This list consisted of three channels, namely, "Eccentricity (Light Loss (Imaging))", "Light Loss (Violet)-A" and "Size (Light Loss (Imaging))". The final feature list was then used to cluster the available dataset consisting of two groups, namely, 25k events and 50k events, each containing data from five cell donors. Gaussian mixture modeling was applied to the cluster datasets described above. Gaussian mixture modeling assumes that the data distribution is a Gaussian mixture. For the purposes of this study, the assumptions were limited to two Gaussian models, one for the singlet and one for the non-singlet populations, respectively. Several clustering techniques were applied, including DBSCAN, BIRCH, K-means, and Spectrum, but the Gaussian mixture model best explained the data and was chosen due to its high specificity and sensitivity. The clustered data was compared to the ground truth DRAQ5 DNA staining indicator, R3(700)-A channel distribution. The performance metrics measured were a) singlet inclusion rate, and b) non-singlet exclusion rate, shown below in Tables 1 and 2 for data with 25k events and data with 50k events, respectively.

[0153] [Table 1]

[0154] [Table 2]

[0155] Regardless of the scope of the appended claims, the present disclosure is also defined by the following paragraphs. 1. A computer-implemented method for classifying analyte data into clusters, comprising: applying a regression model to determine a relationship between the initial set of analyte features and the cluster criteria; generating a sparse set from at most a portion of the initial set of analyte features based on the relationships; generating a classification model based on the sparse set; and applying a classification model to classify the analyte data into clusters. 2. The computer-implemented method of claim 1, wherein the analyte data is flow cytometer data. 3. The computer-implemented method of claim 2, wherein the cluster criterion is the association of analyte data with singlets. 4. The computer-implemented method of claim 3, wherein the clusters include singlet clusters and non-singlet clusters. 5. The computer-implemented method of claim 4, wherein the non-singlet cluster comprises a doublet or an aggregate.

[0156] 6. The computer-implemented method of any one of paragraphs 2 to 5, wherein the analyte feature comprises a size feature, an imaging feature, a scattering feature, or any combination thereof. 7. The computer-implemented method of claim 6, wherein the analyte features include imaging features. 8. The computer-implemented method of any one of the preceding claims, wherein the classification model comprises a mixture model. 9. The computer-implemented method of claim 8, wherein the mixture model comprises a Gaussian mixture model. 10. The computer-implemented method of any one of paragraphs 1 to 7, wherein the classification model includes a density-based spatial clustering algorithm.

[0157] 11. The computer-implemented method of claim 10, wherein the density-based spatial clustering algorithm comprises a density-based spatial clustering for applications with noise (DBSCAN) algorithm. 12. The computer-implemented method of any one of paragraphs 1 to 7, wherein the classification model includes a balanced iterative reduction and clustering using a hierarchy (BIRCH) algorithm. 13. The computer-implemented method of any one of paragraphs 1 to 7, wherein the classification model comprises a K-means clustering algorithm. 14. The computer-implemented method of any one of paragraphs 1 to 7, wherein the classification model includes a spectral clustering algorithm. 15. The computer-implemented method of any one of the preceding claims, wherein the initial set of analyte features comprises between 5 and 20 analyte features.

[0158] 16. The computer-implemented method of claim 15, wherein the initial set of analyte features includes between 7 and 15 analyte features. 17. The computer-implemented method of claim 16, wherein the initial set of analyte features includes 9 to 11 analyte features. 18. A computer-implemented method according to any one of the preceding claims, wherein the initial set of analyte features includes 10% or more of the possible analyte features. 19. The computer-implemented method of claim 18, wherein the initial set of analyte features includes 15% or more of the possible analyte features. 20. The computer-implemented method of claim 19, wherein the initial set of analyte features includes 20% or more of the possible analyte features.

[0159] 21. The computer-implemented method of any one of the preceding claims, wherein the sparse set of analyte features comprises between 2 and 10 analyte features. 22. The computer-implemented method of claim 21, wherein the sparse set of analyte features comprises 2 to 5 analyte features. 23. The computer-implemented method of claim 22, wherein the sparse set of analyte features includes 2 to 4 analyte features. 24. The computer-implemented method of any one of the preceding claims, wherein classifying the analyte data includes including 90% or more of the analyte data associated with the cluster criterion in a cluster associated with the cluster criterion. 25. The computer-implemented method of claim 24, wherein classifying the analyte data includes including 95% or more of the analyte data associated with the cluster criterion in a cluster associated with the cluster criterion.

[0160] 26. The computer-implemented method of any one of the preceding claims, wherein classifying the analyte data includes including 97% or more of the analyte data associated with the cluster criterion in a cluster associated with the cluster criterion. 27. The computer-implemented method of any one of paragraphs 1 to 23, wherein classifying the analyte data includes excluding 85% or more of the analyte data that is not associated with the cluster criteria from clusters associated with the cluster criteria. 28. The computer-implemented method of claim 27, wherein classifying the analyte data includes excluding 90% or more of the analyte data that is not associated with the cluster criteria from clusters associated with the cluster criteria. 29. The computer-implemented method of claim 28, wherein classifying the analyte data includes excluding 92% or more of the analyte data that is not associated with the cluster criteria from clusters associated with the cluster criteria.

[0161] 30. A system comprising a memory operatively coupled to a processor, the memory, when executed by the processor, causing the processor to: applying a regression model to determine a relationship between the initial set of analyte features and the cluster criteria; generating a sparse set from at most a portion of the initial set of analyte features based on the relationships; Generate a classification model based on the sparse set; A system that applies a classification model to classify analyte data into clusters. 31. The system of claim 30, wherein the analyte data is flow cytometer data. 32. The system described in paragraph 31, wherein the cluster criterion is association of flow cytometer data with singlets. 33. The system of claim 32, wherein the clusters include singlet clusters and non-singlet clusters. 34. The system of claim 33, wherein the non-singlet cluster comprises a doublet or an aggregate.

[0162] 35. The system of any one of claims 31 to 34, wherein the analyte feature comprises a size feature, an imaging feature, a scattering feature, or any combination thereof. 36. The system of claim 35, wherein the analyte feature comprises an imaging feature. 37. The system of any one of claims 30 to 36, wherein the classification model includes a mixture model. 38. The system of claim 37, wherein the mixture model comprises a Gaussian mixture model. 39. The system of any one of clauses 30 to 36, wherein the classification model includes a density-based spatial clustering algorithm.

[0163] 40. The system of claim 39, wherein the density-based spatial clustering algorithm comprises a density-based spatial clustering for applications with noise (DBSCAN) algorithm. 41. The system of any one of clauses 30 to 36, wherein the classification model includes a hierarchical balanced iterative reduction and clustering (BIRCH) algorithm. 42. The system of any one of clauses 30 to 36, wherein the classification model includes a K-means clustering algorithm. 43. The system of any one of clauses 30 to 36, wherein the classification model includes a spectral clustering algorithm. 44. The system of any one of clauses 30 to 43, wherein the initial set of analyte features includes 5 to 20 analyte features.

[0164] 45. The system of claim 44, wherein the initial set of analyte features includes between 7 and 15 analyte features. 46. ​​The system of claim 45, wherein the initial set of analyte features includes 9 to 11 analyte features. 47. The system of any one of paragraphs 30 to 46, wherein the initial set of analyte features includes 10% or more of the possible analyte features. 48. The system of claim 47, wherein the initial set of analyte features includes 15% or more of the possible analyte features. 49. The system of claim 48, wherein the initial set of analyte features includes 20% or more of the possible analyte features.

[0165] 50. The system of any one of clauses 30 to 49, wherein the sparse set of analyte features includes 2 to 10 analyte features. 51. The system of claim 50, wherein the sparse set of analyte features includes 2 to 5 analyte features. 52. The system of claim 51, wherein the sparse set of analyte features includes 2 to 4 analyte features. 53. The system of any one of clauses 30 to 52, wherein classifying the analyte data includes including 90% or more of the analyte data associated with the cluster criteria in a cluster associated with the cluster criteria. 54. The system of claim 53, wherein classifying the analyte data includes including 95% or more of the analyte data associated with the cluster criteria in a cluster associated with the cluster criteria.

[0166] 55. The system of claim 54, wherein classifying the analyte data includes including 97% or more of the analyte data associated with the cluster criteria in a cluster associated with the cluster criteria. 56. The system of any one of clauses 30 to 52, wherein classifying the analyte data includes excluding 85% or more of the analyte data that is not associated with the cluster criteria from clusters associated with the cluster criteria. 57. The system of claim 56, wherein classifying the analyte data includes excluding 90% or more of the analyte data that is not associated with the cluster criteria from clusters associated with the cluster criteria. 58. The system of claim 57, wherein classifying the analyte data includes excluding 92% or more of the analyte data not associated with the cluster criteria from clusters associated with the cluster criteria. 59. The system of any one of clauses 30 to 58, further comprising a display configured to output classified analyte data. 60. The system of any one of paragraphs 30 to 59, further comprising a flow cytometer operably connected to the processor.

[0167] 61. A non-transitory computer-readable storage medium having stored thereon instructions for classifying analyte data into clusters by a method, the method comprising: applying a regression model to determine a relationship between the initial set of analyte features and the cluster criteria; generating a sparse set from at most a portion of the initial set of analyte features based on the relationships; generating a classification model based on the sparse set; and applying a classification model to classify the analyte data into clusters. 62. The non-transitory computer-readable storage medium of paragraph 61, wherein the analyte data is flow cytometer data. 63. The non-transitory computer-readable storage medium of claim 62, wherein the cluster criterion is an association between analyte data and singlets. 64. The non-transitory computer-readable storage medium of claim 63, wherein the clusters include singlet clusters and non-singlet clusters. 65. The non-transitory computer-readable storage medium of claim 64, wherein the non-singlet cluster comprises a doublet or an aggregate.

[0168] 66. The non-transitory computer-readable storage medium of any one of claims 62 to 65, wherein the analyte feature comprises a size feature, an imaging feature, a scattering feature, or any combination thereof. 67. The non-transitory computer-readable storage medium of claim 66, wherein the analyte feature comprises an imaging feature. 68. The non-transitory computer-readable storage medium of any one of claims 61 to 67, wherein the classification model includes a mixture model. 69. The non-transitory computer-readable storage medium of claim 68, wherein the mixture model includes a Gaussian mixture model. 70. The non-transitory computer-readable storage medium of any one of clauses 61 to 67, wherein the classification model includes a density-based spatial clustering algorithm.

[0169] 71. The non-transitory computer-readable storage medium of claim 70, wherein the density-based spatial clustering algorithm comprises a density-based spatial clustering for noisy applications (DBSCAN) algorithm. 72. The non-transitory computer-readable storage medium of any one of clauses 61 to 67, wherein the classification model includes a balanced iterative reduction and clustering using a hierarchy (BIRCH) algorithm. 73. The non-transitory computer-readable storage medium of any one of clauses 61 to 67, wherein the classification model includes a K-means clustering algorithm. 74. The non-transitory computer-readable storage medium of any one of paragraphs 61 to 67, wherein the classification model includes a spectral clustering algorithm. 75. The non-transitory computer-readable storage medium of any one of paragraphs 61 to 74, wherein the initial set of analyte features includes 5 to 20 analyte features.

[0170] 76. The non-transitory computer-readable storage medium of claim 75, wherein the initial set of analyte features includes between 7 and 15 analyte features. 77. The non-transitory computer-readable storage medium of claim 76, wherein the initial set of analyte features includes 9 to 11 analyte features. 78. The non-transitory computer-readable storage medium of any one of paragraphs 61 to 77, wherein the initial set of analyte features includes 10% or more of the possible analyte features. 79. The non-transitory computer-readable storage medium of paragraph 78, wherein the initial set of analyte features includes 15% or more of the possible analyte features. 80. The non-transitory computer-readable storage medium of paragraph 79, wherein the initial set of analyte features includes 20% or more of the possible analyte features.

[0171] 81. The non-transitory computer-readable storage medium of any one of claims 61 to 80, wherein the sparse set of analyte features includes 2 to 10 analyte features. 82. The non-transitory computer-readable storage medium of claim 81, wherein the sparse set of analyte features includes 2 to 5 analyte features. 83. The non-transitory computer-readable storage medium of claim 82, wherein the sparse set of analyte features includes 2 to 4 analyte features. 84. The non-transitory computer-readable storage medium of any one of clauses 61 to 83, wherein classifying the analyte data includes including 90% or more of the analyte data associated with the cluster criteria in a cluster associated with the cluster criteria. 85. The non-transitory computer-readable storage medium of claim 84, wherein classifying the analyte data includes including 95% or more of the analyte data associated with the cluster criteria in a cluster associated with the cluster criteria.

[0172] 86. The non-transitory computer-readable storage medium of claim 85, wherein classifying the analyte data includes including 97% or more of the analyte data associated with the cluster criteria in a cluster associated with the cluster criteria. 87. The non-transitory computer-readable storage medium of any one of clauses 61 to 83, wherein classifying the analyte data includes excluding 85% or more of the analyte data that is not associated with the cluster criteria from clusters associated with the cluster criteria. 88. The non-transitory computer-readable storage medium of paragraph 87, wherein classifying the analyte data includes excluding 90% or more of the analyte data that is not associated with the cluster criteria from clusters associated with the cluster criteria. 89. The non-transitory computer storage medium of claim 88, wherein classifying the analyte data includes excluding 92% or more of the analyte data not associated with the cluster criteria from clusters associated with the cluster criteria.

[0173] 90. A computer-implemented method for classifying analyte data into clusters, comprising: (a) providing analyte data to a system having instructions stored thereon, the instructions, when executed by a processor, causing the processor to: applying a regression model to determine a relationship between the initial set of analyte features and the cluster criteria; generating a sparse set from at most a portion of the initial set of analyte features based on the relationships; Generate a classification model based on the sparse set; applying a classification model to classify the analyte data into clusters; (b) receiving the classified analyte data from the processor. 91. The computer-implemented method of paragraph 90, wherein the analyte data is flow cytometer data. 92. The computer-implemented method of claim 91, wherein the cluster criterion is association of analyte data with singlets. 93. The computer-implemented method of claim 92, wherein the clusters include singlet clusters and non-singlet clusters. 94. The computer-implemented method of claim 93, wherein the non-singlet cluster comprises a doublet or an aggregate.

[0174] 95. The computer-implemented method of any one of paragraphs 91 to 94, wherein the analyte feature comprises a size feature, an imaging feature, a scattering feature, or any combination thereof. 96. The computer-implemented method of claim 95, wherein the analyte features include imaging features. 97. The computer-implemented method of any one of paragraphs 90 to 96, wherein the classification model includes a mixture model. 98. The computer-implemented method of any one of paragraphs 90 to 97, wherein the mixture model includes a Gaussian mixture model. 99. The computer-implemented method of any one of paragraphs 90 to 96, wherein the classification model includes a density-based spatial clustering algorithm.

[0175] 100. The computer-implemented method of claim 99, wherein the density-based spatial clustering algorithm comprises a density-based spatial clustering of applications with noise (DBSCAN) algorithm. 101. The computer-implemented method of any one of paragraphs 90 to 96, wherein the classification model includes a balanced iterative reduction and clustering using a hierarchy (BIRCH) algorithm. 102. The computer-implemented method of any one of paragraphs 90 to 96, wherein the classification model includes a K-means clustering algorithm. 103. The computer-implemented method of any one of paragraphs 90 to 96, wherein the classification model includes a spectral clustering algorithm. 104. The computer-implemented method of any one of paragraphs 90 to 103, wherein the initial set of analyte features includes between 5 and 20 analyte features.

[0176] 105. The computer-implemented method of claim 104, wherein the initial set of analyte features includes between 7 and 15 analyte features. 106. The computer-implemented method of claim 105, wherein the initial set of analyte features includes 9 to 11 analyte features. 107. The computer-implemented method of any one of paragraphs 90 to 106, wherein the initial set of analyte features includes 10% or more of the possible analyte features. 108. The computer-implemented method of claim 107, wherein the initial set of analyte features includes 15% or more of the possible analyte features. 109. The computer-implemented method of claim 108, wherein the initial set of analyte features includes 20% or more of the possible analyte features.

[0177] 110. The computer-implemented method of any one of paragraphs 90 to 109, wherein the sparse set of analyte features includes between 2 and 10 analyte features. 111. The computer-implemented method of claim 110, wherein the sparse set of analyte features includes 2 to 5 analyte features. 112. The computer-implemented method of claim 111, wherein the sparse set of analyte features includes 2 to 4 analyte features. 113. The computer-implemented method of any one of paragraphs 90 to 112, wherein classifying the analyte data includes including 90% or more of the analyte data associated with the cluster criterion in a cluster associated with the cluster criterion. 114. The computer-implemented method of claim 113, wherein classifying the analyte data includes including 95% or more of the analyte data associated with the cluster criterion in a cluster associated with the cluster criterion.

[0178] 115. The computer-implemented method of claim 114, wherein classifying the analyte data includes including 97% or more of the analyte data associated with the cluster criterion in a cluster associated with the cluster criterion. 116. The computer-implemented method of any one of paragraphs 90 to 112, wherein classifying the analyte data includes excluding 85% or more of the analyte data that is not associated with the cluster criteria from clusters associated with the cluster criteria. 117. The computer-implemented method of claim 116, wherein classifying the analyte data includes excluding 90% or more of the analyte data that is not associated with the cluster criteria from clusters associated with the cluster criteria. 118. The computer-implemented method of claim 117, wherein classifying the analyte data includes excluding 92% or more of the analyte data that is not associated with the cluster criteria from clusters associated with the cluster criteria. 119. The computer-implemented method of any one of paragraphs 90 to 118, wherein the method includes receiving the classified analyte data on a display.

[0179] Although the foregoing disclosure has been described in some detail by way of illustration and example for clarity of understanding, it will be readily apparent to those skilled in the art in light of the teachings of the present disclosure that certain changes and modifications may be made thereto without departing from the spirit or scope of the appended claims.

[0180] Thus, the above description merely illustrates the principles of the present disclosure. It will be understood that those skilled in the art can devise various arrangements that embody the principles of the present disclosure and fall within the spirit and scope thereof, although not expressly described or shown herein. Furthermore, all examples and conditional language recited herein are intended primarily to aid the reader in understanding the principles of the present disclosure and the concepts contributed by the present disclosure to advance the art, and are not to be construed as being limited to such specifically recited examples and conditions. Furthermore, all statements herein that describe principles, aspects, and embodiments of the present disclosure, as well as specific examples thereof, are intended to encompass both structural and functional equivalents thereof. Additionally, such equivalents are intended to include both currently known equivalents and equivalents developed in the future, i.e., any elements developed that perform the same function, regardless of structure. Furthermore, nothing disclosed herein is intended to be made available to the public, regardless of whether such disclosure is expressly recited in the claims.

[0181] Therefore, the scope of the present disclosure is not intended to be limited to the exemplary embodiments shown and described herein. Rather, the scope and spirit of the present disclosure is embodied by the appended claims. In the claims, 35 U.S.C. 112(f) or 35 U.S.C. 112(6) is expressly defined as being cited for a limitation in a claim only when the precise phrase "means for" or the precise phrase "step for" is recited at the beginning of such limitation in the claim, and if such precise phrase is not used in the limitation in the claim, 35 U.S.C. 112(f) or 35 U.S.C. 112(6) is not cited.

[0182] CROSS-REFERENCE TO RELATED APPLICATIONS Pursuant to 35 U.S.C. §119(e), this application claims priority to the filing date of U.S. Provisional Patent Application No. 63 / 465,057, filed May 9, 2023, which is incorporated herein by reference in its entirety.

Claims

1. 1. A computer-implemented method for classifying analyte data into clusters, the method comprising, via a processor: applying a regression model to determine a relationship between the initial set of analyte features and the cluster criteria; generating a sparse set from at most a portion of the initial set of analyte features based on the relationship; generating a classification model based on the sparse set; and applying the classification model to classify the analyte data into the clusters.

2. The computer-implemented method of claim 1 , wherein the analyte data is flow cytometer data.

3. The computer-implemented method of claim 2 , wherein the cluster criterion is an association of the analyte data with singlets.

4. The computer-implemented method of claim 3 , wherein the clusters include singlet clusters and non-singlet clusters.

5. The computer-implemented method of claim 4 , wherein the non-singlet cluster comprises a doublet or an aggregate.

6. The computer-implemented method of any one of claims 2 to 5, wherein the analyte features include size features, imaging features, scattering features, or any combination thereof.

7. The computer-implemented method of claim 6 , wherein the analyte features include imaging features.

8. 8. The computer-implemented method of claim 1, wherein the classification model comprises a mixture model, preferably a Gaussian mixture model, or a Density-Based Spatial Clustering for Applications with Noise (DBSCAN) algorithm, or a Hierarchical Balanced Iterative Reduction and Clustering (BIRCH) algorithm, or a K-means clustering algorithm, or a Spectral Clustering algorithm.

9. The computer-implemented method of any one of claims 1 to 8, wherein the initial set of analyte features comprises between 5 and 20 analyte features.

10. The computer-implemented method of any one of claims 1 to 9, wherein the initial set of analyte features comprises 10% or more of the possible analyte features.

11. The computer-implemented method of any one of claims 1 to 10, wherein the sparse set of analyte features comprises between 2 and 10 analyte features.

12. 12. The computer-implemented method of claim 1, wherein classifying the analyte data comprises including 90% or more of the analyte data associated with the cluster criterion in a cluster associated with the cluster criterion.

13. 1. A system comprising a memory operatively coupled to a processor, the memory including instructions stored in the memory, the instructions, when executed by the processor, causing the processor to: applying a regression model to determine a relationship between the initial set of analyte features and the cluster criteria; generating a sparse set from at most a portion of the initial set of analyte features based on the relationship; generating a classification model based on the sparse set; The system applies the classification model to classify analyte data into clusters.

14. 1. A non-transitory computer readable storage medium having stored thereon instructions for classifying analyte data into clusters by a method, the method comprising: applying a regression model to determine a relationship between the initial set of analyte features and the cluster criteria; generating a sparse set from at most a portion of the initial set of analyte features based on the relationship; generating a classification model based on the sparse set; and applying the classification model to classify the analyte data into the clusters.

15. 1. A computer-implemented method for classifying analyte data into clusters, the method comprising: (a) providing analyte data to a system having instructions stored thereon, the instructions, when executed by a processor, causing the processor to: applying a regression model to determine a relationship between the initial set of analyte features and the cluster criteria; generating a sparse set from at most a portion of the initial set of analyte features based on the relationship; generating a classification model based on the sparse set; applying said classification model to classify said analyte data into said clusters; (b) receiving the classified analyte data from the processor.